BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 709480 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C28H26N6O/c1-19-13-33-34(17-19)18-21-4-2-20(3-5-21)10-23-12-25(16-30-14-23)28(35)32-15-22-6-7-26-24(11-22)8-9-31-27(26)29/h2-9,11-14,16-17H,10,15,18H2,1H3,(H2,29,31)(H,32,35) XZGMSMZMNPUQHT-UHFFFAOYSA-N 359614 N-[(1-Aminoisoquinolin-6-yl)methyl]-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 1::US11242333, Example 1 Plasma kallikrein Human 3.86 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359614&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117889681 386399068 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709481 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3cnc4[nH]ccc4c3)cc2)c1 InChI=1S/C26H24N6O/c1-18-11-31-32(16-18)17-20-4-2-19(3-5-20)8-21-9-24(15-27-12-21)26(33)30-14-22-10-23-6-7-28-25(23)29-13-22/h2-7,9-13,15-16H,8,14,17H2,1H3,(H,28,29)(H,30,33) JJUHBFMQMARLNX-UHFFFAOYSA-N 359615 5-({4-[(4-Methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-3-carboxamide::US10221161, Example 2::US11242333, Example 2 Plasma kallikrein Human 216 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359615&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117889991 386399069 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709482 Cc1cnn(Cc2ccc(Cc3ccnc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C28H26N6O/c1-19-15-33-34(17-19)18-21-4-2-20(3-5-21)12-22-8-10-30-26(14-22)28(35)32-16-23-6-7-25-24(13-23)9-11-31-27(25)29/h2-11,13-15,17H,12,16,18H2,1H3,(H2,29,31)(H,32,35) DZDSGRZPTVIORQ-UHFFFAOYSA-N 359616 N-[(1-Aminoisoquinolin-6-yl)methyl]-4-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-2-carboxamide::US10221161, Example 3::US11242333, Example 3 Plasma kallikrein Human 159 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359616&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117889735 386399070 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709483 Cc1cnn(Cc2ccc(Cc3ccnc(c3)C(=O)NCc3cnc4[nH]ccc4c3)cc2)c1 InChI=1S/C26H24N6O/c1-18-13-31-32(16-18)17-20-4-2-19(3-5-20)10-21-6-8-27-24(12-21)26(33)30-15-22-11-23-7-9-28-25(23)29-14-22/h2-9,11-14,16H,10,15,17H2,1H3,(H,28,29)(H,30,33) WRUWFRKMFQIBTK-UHFFFAOYSA-N 359617 4-({4-[(4-Methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-2-carboxamide::US10221161, Example 4::US11242333, Example 4 Plasma kallikrein Human 6610 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359617&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121406191 386399071 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709484 Nc1nccc2cc(CNC(=O)c3ccc(=O)n(Cc4ccc(Cn5ccccc5=O)cc4)c3)ccc12 InChI=1S/C29H25N5O3/c30-28-25-10-8-22(15-23(25)12-13-31-28)16-32-29(37)24-9-11-27(36)34(19-24)18-21-6-4-20(5-7-21)17-33-14-2-1-3-26(33)35/h1-15,19H,16-18H2,(H2,30,31)(H,32,37) UJFXLGBMZVPDMP-UHFFFAOYSA-N 359618 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-oxo-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 5::US11242333, Example 5 Plasma kallikrein Human 24.7 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359618&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117907897 386399072 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709485 O=C(NCc1cnc2[nH]ccc2c1)c1ccc(=O)n(Cc2ccc(Cn3ccccc3=O)cc2)c1 InChI=1S/C27H23N5O3/c33-24-3-1-2-12-31(24)16-19-4-6-20(7-5-19)17-32-18-23(8-9-25(32)34)27(35)30-15-21-13-22-10-11-28-26(22)29-14-21/h1-14,18H,15-17H2,(H,28,29)(H,30,35) LSSBHLFUNMHFAM-UHFFFAOYSA-N 359619 6-Oxo-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-3-carboxamide::US10221161, Example 6::US11242333, Example 6 Plasma kallikrein Human 580 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359619&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117907999 386399073 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709486 Cc1cnn(Cc2ccc(cc2)C(O)c2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1 InChI=1S/C28H26N6O2/c1-18-12-33-34(16-18)17-19-2-5-21(6-3-19)26(35)23-11-24(15-30-14-23)28(36)32-13-20-4-7-25-22(10-20)8-9-31-27(25)29/h2-12,14-16,26,35H,13,17H2,1H3,(H2,29,31)(H,32,36) LJHHAYREDCAYJE-UHFFFAOYSA-N 359621 N-((1-Aminoisoquinolin-6-yl)methyl)-5-(hydroxy(4-((4-methyl-1H-pyrazol-1-yl)methyl)phenyl)methyl)nicotinamide::US10221161, Example 7::US11242333, Example 7 Plasma kallikrein Human 35.3 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359621&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117890055 386399075 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709487 Cc1cnn(Cc2ccc(Cc3cc(ncn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C27H25N7O/c1-18-13-33-34(15-18)16-20-4-2-19(3-5-20)11-23-12-25(32-17-31-23)27(35)30-14-21-6-7-24-22(10-21)8-9-29-26(24)28/h2-10,12-13,15,17H,11,14,16H2,1H3,(H2,28,29)(H,30,35) YVWZOLYJJRHVHL-UHFFFAOYSA-N 359622 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrimidine-4-carboxamide::US10221161, Example 8::US11242333, Example 8 Plasma kallikrein Human 119 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359622&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117890488 386399076 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709488 Cc1cnn(Cc2ccc(Cc3cncc(n3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C27H25N7O/c1-18-12-32-34(16-18)17-20-4-2-19(3-5-20)11-23-14-29-15-25(33-23)27(35)31-13-21-6-7-24-22(10-21)8-9-30-26(24)28/h2-10,12,14-16H,11,13,17H2,1H3,(H2,28,30)(H,31,35) XNGKXROWONCSGX-UHFFFAOYSA-N 359623 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazine-2-carboxamide::US10221161, Example 9::US11242333, Example 9 Plasma kallikrein Human 30.8 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359623&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117890033 386399077 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709489 Cc1ccc2cc(Cc3cncc(n3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1 InChI=1S/C26H22N6O/c1-16-2-5-20-10-17(4-7-23(20)31-16)12-21-14-28-15-24(32-21)26(33)30-13-18-3-6-22-19(11-18)8-9-29-25(22)27/h2-11,14-15H,12-13H2,1H3,(H2,27,29)(H,30,33) CGNIOLXFEPYYHB-UHFFFAOYSA-N 359624 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-[(2-methylquinolin-6-yl)methyl]pyrazine-2-carboxamide::US10221161, Example 10::US11242333, Example 10 Plasma kallikrein Human 194 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359624&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117890082 386399078 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709490 Cc1cnn(Cc2ccc(Cc3cnnc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C27H25N7O/c1-18-13-32-34(16-18)17-20-4-2-19(3-5-20)10-22-12-25(33-31-15-22)27(35)30-14-21-6-7-24-23(11-21)8-9-29-26(24)28/h2-9,11-13,15-16H,10,14,17H2,1H3,(H2,28,29)(H,30,35) DDCNHPCNBRRWTO-UHFFFAOYSA-N 359625 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridazine-3-carboxamide::US10221161, Example 11::US11242333, Example 11 Plasma kallikrein Human 82.3 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359625&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117890119 386399079 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709491 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3c(C)nc4[nH]ccc(C)c34)cc2)c1 InChI=1S/C28H28N6O/c1-18-12-32-34(16-18)17-22-6-4-21(5-7-22)10-23-11-24(14-29-13-23)28(35)31-15-25-20(3)33-27-26(25)19(2)8-9-30-27/h4-9,11-14,16H,10,15,17H2,1-3H3,(H,30,33)(H,31,35) ZBVFUONSGPAIOP-UHFFFAOYSA-N 359626 N-({2,4-Dimethyl-7H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 12 Plasma kallikrein Human 244 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359626&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393177 386399080 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709492 Cc1nc2[nH]ccc(C)c2c1CNC(=O)c1cncc(Cc2ccc3nc(C)ccc3c2)c1 InChI=1S/C27H25N5O/c1-16-8-9-29-26-25(16)23(18(3)32-26)15-30-27(33)22-12-20(13-28-14-22)10-19-5-7-24-21(11-19)6-4-17(2)31-24/h4-9,11-14H,10,15H2,1-3H3,(H,29,32)(H,30,33) MPEZSZKUEPIWCM-UHFFFAOYSA-N 359627 N-({2,4-Dimethyl-7H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 13 Plasma kallikrein Human 923 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359627&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393186 386399081 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709493 Nc1nccc2cc(CNC(=O)c3ccc(=O)n(Cc4csc(n4)-c4ccccc4)c3)ccc12 InChI=1S/C26H21N5O2S/c27-24-22-8-6-17(12-19(22)10-11-28-24)13-29-25(33)20-7-9-23(32)31(14-20)15-21-16-34-26(30-21)18-4-2-1-3-5-18/h1-12,14,16H,13,15H2,(H2,27,28)(H,29,33) TVMQOXCUTCHUPL-UHFFFAOYSA-N 359628 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-oxo-1-[(2-phenyl-1,3-thiazol-4-yl)methyl]pyridine-3-carboxamide::US10221161, Example 14::US11242333, Example 14 Plasma kallikrein Human 2670 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359628&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393161 386399082 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709494 Cc1cnn(Cc2ccc(Cn3cc(ccc3=O)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C28H26N6O2/c1-19-13-32-34(15-19)17-21-4-2-20(3-5-21)16-33-18-24(7-9-26(33)35)28(36)31-14-22-6-8-25-23(12-22)10-11-30-27(25)29/h2-13,15,18H,14,16-17H2,1H3,(H2,29,30)(H,31,36) JRVPVSFGNJKYLB-UHFFFAOYSA-N 359629 N-[(1-Aminoisoquinolin-6-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-6-oxopyridine-3-carboxamide::US10221161, Example 15::US11242333, Example 15 Plasma kallikrein Human 159 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359629&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117890144 386399083 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709495 Cc1ccc2cc(Cn3cc(ccc3=O)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1 InChI=1S/C27H23N5O2/c1-17-2-5-21-13-19(4-8-24(21)31-17)15-32-16-22(6-9-25(32)33)27(34)30-14-18-3-7-23-20(12-18)10-11-29-26(23)28/h2-13,16H,14-15H2,1H3,(H2,28,29)(H,30,34) VRTRGFXOHVRQQQ-UHFFFAOYSA-N 359630 N-[(1-Aminoisoquinolin-6-yl)methyl]-1-[(2-methylquinolin-6-yl)methyl]-6-oxopyridine-3-carboxamide::US10221161, Example 16::US11242333, Example 16 Plasma kallikrein Human 179 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359630&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393202 386399084 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709496 Cc1ccc2cc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1 InChI=1S/C27H23N5O/c1-17-2-5-22-11-18(4-7-25(22)32-17)10-20-13-23(16-29-14-20)27(33)31-15-19-3-6-24-21(12-19)8-9-30-26(24)28/h2-9,11-14,16H,10,15H2,1H3,(H2,28,30)(H,31,33) YGGSTOCJVHLULA-UHFFFAOYSA-N 359631 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 17::US11242333, Example 17 Plasma kallikrein Human 27.5 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359631&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117890179 386399085 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709497 COc1ncc(cc1Cc1ccc2nc(C)ccc2c1)C(=O)NCc1ccc2c(N)nccc2c1 InChI=1S/C28H25N5O2/c1-17-3-6-21-11-18(5-8-25(21)33-17)12-22-14-23(16-32-28(22)35-2)27(34)31-15-19-4-7-24-20(13-19)9-10-30-26(24)29/h3-11,13-14,16H,12,15H2,1-2H3,(H2,29,30)(H,31,34) RAXAJDWJQASKEB-UHFFFAOYSA-N 359632 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-methoxy-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 18::US11242333, Example 19 Plasma kallikrein Human 702 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359632&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393219 386399086 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709498 COc1ncc(Cc2ccc3nc(C)ccc3c2)cc1C(=O)NCc1ccc2c(N)nccc2c1 InChI=1S/C28H25N5O2/c1-17-3-6-22-12-18(5-8-25(22)33-17)11-20-14-24(28(35-2)32-16-20)27(34)31-15-19-4-7-23-21(13-19)9-10-30-26(23)29/h3-10,12-14,16H,11,15H2,1-2H3,(H2,29,30)(H,31,34) NTARKBOIYLKMIA-UHFFFAOYSA-N 359633 N-[(1-Aminoisoquinolin-6-yl)methyl]-2-methoxy-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 19::US11242333, Example 18 Plasma kallikrein Human 434 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359633&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393195 386399087 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709499 Cc1ccc2cc(Cc3c[nH]c(=O)c(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1 InChI=1S/C27H23N5O2/c1-16-2-5-21-11-17(4-7-24(21)32-16)10-19-13-23(27(34)31-15-19)26(33)30-14-18-3-6-22-20(12-18)8-9-29-25(22)28/h2-9,11-13,15H,10,14H2,1H3,(H2,28,29)(H,30,33)(H,31,34) BWDGDESETBEAIN-UHFFFAOYSA-N 359634 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methylquinolin-6-yl)methyl]-2-oxo-1H-pyridine-3-carboxamide::US10221161, Example 20 Plasma kallikrein Human 621 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359634&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 139269071 386399088 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709500 CNc1ncc(cc1Cc1ccc2nc(C)ccc2c1)C(=O)NCc1ccc2c(N)nccc2c1 InChI=1S/C28H26N6O/c1-17-3-6-21-11-18(5-8-25(21)34-17)12-22-14-23(16-32-27(22)30-2)28(35)33-15-19-4-7-24-20(13-19)9-10-31-26(24)29/h3-11,13-14,16H,12,15H2,1-2H3,(H2,29,31)(H,30,32)(H,33,35) VPCARFQYWNGPJW-UHFFFAOYSA-N 359635 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-(methylamino)-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 21 Plasma kallikrein Human 53.3 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359635&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117889797 386399089 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709501 Cc1ccc2cc(Cc3cnc(C)c(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1 InChI=1S/C28H25N5O/c1-17-3-6-23-12-19(5-8-26(23)33-17)11-21-14-25(18(2)31-16-21)28(34)32-15-20-4-7-24-22(13-20)9-10-30-27(24)29/h3-10,12-14,16H,11,15H2,1-2H3,(H2,29,30)(H,32,34) FAQUHNMIVPDPJH-UHFFFAOYSA-N 359637 N-[(1-Aminoisoquinolin-6-yl)methyl]-2-methyl-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 22 Plasma kallikrein Human 104 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359637&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117890164 386399091 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709502 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccccc4)c3)ccc12 InChI=1S/C23H20N4O/c24-22-21-7-6-17(11-19(21)8-9-26-22)14-27-23(28)20-12-18(13-25-15-20)10-16-4-2-1-3-5-16/h1-9,11-13,15H,10,14H2,(H2,24,26)(H,27,28) HMNZKYMVBHQDLG-UHFFFAOYSA-N 359638 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-benzylpyridine-3-carboxamide::US10221161, Example 23::US11242333, Example 23 Plasma kallikrein Human 40000 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359638&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117890433 386399092 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709503 Nc1nccc2cc(CNC(=O)c3cncc(Cc4csc(n4)-c4ccccc4)c3)ccc12 InChI=1S/C26H21N5OS/c27-24-23-7-6-17(10-20(23)8-9-29-24)14-30-25(32)21-11-18(13-28-15-21)12-22-16-33-26(31-22)19-4-2-1-3-5-19/h1-11,13,15-16H,12,14H2,(H2,27,29)(H,30,32) ACVNKJMNWOONDL-UHFFFAOYSA-N 359639 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-phenyl-1,3-thiazol-4-yl)methyl]pyridine-3-carboxamide::US10221161, Example 24 Plasma kallikrein Human 1710 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359639&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393158 386399093 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709504 COc1cccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1 InChI=1S/C24H22N4O2/c1-30-21-4-2-3-16(12-21)9-18-11-20(15-26-13-18)24(29)28-14-17-5-6-22-19(10-17)7-8-27-23(22)25/h2-8,10-13,15H,9,14H2,1H3,(H2,25,27)(H,28,29) NHVPFJINKKJQSZ-UHFFFAOYSA-N 359640 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(3-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 25::US11242333, Example 25 Plasma kallikrein Human 2640 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359640&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393160 386399094 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709505 COc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cc1 InChI=1S/C24H22N4O2/c1-30-21-5-2-16(3-6-21)10-18-12-20(15-26-13-18)24(29)28-14-17-4-7-22-19(11-17)8-9-27-23(22)25/h2-9,11-13,15H,10,14H2,1H3,(H2,25,27)(H,28,29) RXDWASWWHDDTEG-UHFFFAOYSA-N 359641 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 26::US11242333, Example 26 Plasma kallikrein Human 941 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359641&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393173 386399095 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709506 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(cc4)-n4cccn4)c3)ccc12 InChI=1S/C26H22N6O/c27-25-24-7-4-19(13-21(24)8-10-29-25)16-30-26(33)22-14-20(15-28-17-22)12-18-2-5-23(6-3-18)32-11-1-9-31-32/h1-11,13-15,17H,12,16H2,(H2,27,29)(H,30,33) MJHTYGXMZRJQOL-UHFFFAOYSA-N 359642 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(pyrazol-1-yl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 27::US11242333, Example 27 Plasma kallikrein Human 1010 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359642&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393199 386399096 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709507 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc5ccncc5c4)c3)ccc12 InChI=1S/C26H21N5O/c27-25-24-4-2-18(11-21(24)6-8-30-25)14-31-26(32)23-12-19(13-29-16-23)9-17-1-3-20-5-7-28-15-22(20)10-17/h1-8,10-13,15-16H,9,14H2,(H2,27,30)(H,31,32) QWPOIDBZQCSTHS-UHFFFAOYSA-N 359643 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-(isoquinolin-7-ylmethyl)pyridine-3-carboxamide::US10221161, Example 28::US11242333, Example 28 Plasma kallikrein Human 1100 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359643&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393146 386399097 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709508 COc1ccccc1Cc1cncc(c1)C(=O)NCc1ccc2c(N)nccc2c1 InChI=1S/C24H22N4O2/c1-30-22-5-3-2-4-19(22)11-17-12-20(15-26-13-17)24(29)28-14-16-6-7-21-18(10-16)8-9-27-23(21)25/h2-10,12-13,15H,11,14H2,1H3,(H2,25,27)(H,28,29) RJBICVKPFVWOFZ-UHFFFAOYSA-N 359644 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 29::US11242333, Example 29 Plasma kallikrein Human 20200 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359644&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393216 386399098 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709509 Nc1nccc2cc(CNC(=O)c3cncc(Cc4cccc(c4)-n4cccn4)c3)ccc12 InChI=1S/C26H22N6O/c27-25-24-6-5-19(12-21(24)7-9-29-25)16-30-26(33)22-13-20(15-28-17-22)11-18-3-1-4-23(14-18)32-10-2-8-31-32/h1-10,12-15,17H,11,16H2,(H2,27,29)(H,30,33) QCNNYPSWAPTRPO-UHFFFAOYSA-N 359645 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[3-(pyrazol-1-yl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 30::US11242333, Example 30 Plasma kallikrein Human 302 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359645 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359645&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393194 386399099 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709510 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc5ncccc5c4)c3)ccc12 InChI=1S/C26H21N5O/c27-25-23-5-3-18(12-20(23)7-9-30-25)15-31-26(32)22-13-19(14-28-16-22)10-17-4-6-24-21(11-17)2-1-8-29-24/h1-9,11-14,16H,10,15H2,(H2,27,30)(H,31,32) XUTIWWYHRPIIGM-UHFFFAOYSA-N 359646 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-(quinolin-6-ylmethyl)pyridine-3-carboxamide::US10221161, Example 31::US11242333, Example 31 Plasma kallikrein Human 144 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359646&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117889860 386399100 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709511 Nc1nccc2cc(CNC(=O)c3cncc(Cc4cccc(Cn5cccn5)c4)c3)ccc12 InChI=1S/C27H24N6O/c28-26-25-6-5-20(13-23(25)7-9-30-26)16-31-27(34)24-14-22(15-29-17-24)12-19-3-1-4-21(11-19)18-33-10-2-8-32-33/h1-11,13-15,17H,12,16,18H2,(H2,28,30)(H,31,34) KXHZGAGGNIYIJJ-UHFFFAOYSA-N 359647 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[3-(pyrazol-1-ylmethyl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 32::US11242333, Example 32 Plasma kallikrein Human 237 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359647&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393182 386399101 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709512 COc1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccc1Cn1cc(C)cn1 InChI=1S/C29H28N6O2/c1-19-13-34-35(17-19)18-24-5-3-20(12-27(24)37-2)9-22-11-25(16-31-14-22)29(36)33-15-21-4-6-26-23(10-21)7-8-32-28(26)30/h3-8,10-14,16-17H,9,15,18H2,1-2H3,(H2,30,32)(H,33,36) GTAQUAIETWGMKZ-UHFFFAOYSA-N 359648 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({3-methoxy-4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 33::US11242333, Example 33 Plasma kallikrein Human 17.1 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359648 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359648&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117889845 386399102 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709513 COCCOc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cc1 InChI=1S/C26H26N4O3/c1-32-10-11-33-23-5-2-18(3-6-23)12-20-14-22(17-28-15-20)26(31)30-16-19-4-7-24-21(13-19)8-9-29-25(24)27/h2-9,13-15,17H,10-12,16H2,1H3,(H2,27,29)(H,30,31) VWAFTKDLCVIHNB-UHFFFAOYSA-N 359649 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(2-methoxyethoxy)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 34::US11242333, Example 34 Plasma kallikrein Human 1020 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359649&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393208 386399103 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709514 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)S(=O)(=O)c4ccccc4)c3)ccc12 InChI=1S/C27H28N6O3S/c28-26-25-7-6-20(14-22(25)8-9-30-26)17-31-27(34)23-15-21(16-29-18-23)19-32-10-12-33(13-11-32)37(35,36)24-4-2-1-3-5-24/h1-9,14-16,18H,10-13,17,19H2,(H2,28,30)(H,31,34) GSABBNCJRVLTCT-UHFFFAOYSA-N 359650 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(benzenesulfonyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 35::US11242333, Example 35 Plasma kallikrein Human 3510 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359650&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393203 386399104 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709515 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)C(=O)c4ccccc4)c3)ccc12 InChI=1S/C28H28N6O2/c29-26-25-7-6-20(14-23(25)8-9-31-26)17-32-27(35)24-15-21(16-30-18-24)19-33-10-12-34(13-11-33)28(36)22-4-2-1-3-5-22/h1-9,14-16,18H,10-13,17,19H2,(H2,29,31)(H,32,35) QQISCDLIEFYLAP-UHFFFAOYSA-N 359651 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-benzoylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 36::US11242333, Example 36 Plasma kallikrein Human 6650 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359651&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393205 386399105 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709516 Cc1cnn(CC2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)c1 InChI=1S/C27H31N7O/c1-19-12-32-34(16-19)18-20-5-8-33(9-6-20)17-22-11-24(15-29-13-22)27(35)31-14-21-2-3-25-23(10-21)4-7-30-26(25)28/h2-4,7,10-13,15-16,20H,5-6,8-9,14,17-18H2,1H3,(H2,28,30)(H,31,35) HYHCEUBNRXJNAP-UHFFFAOYSA-N 359652 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-methylpyrazol-1-yl)methyl]piperidin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 37 Plasma kallikrein Human 1180 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359652&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393163 386399106 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709517 CN1CCOc2cc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc12 InChI=1S/C26H25N5O2/c1-31-8-9-33-24-13-17(3-5-23(24)31)10-19-12-21(16-28-14-19)26(32)30-15-18-2-4-22-20(11-18)6-7-29-25(22)27/h2-7,11-14,16H,8-10,15H2,1H3,(H2,27,29)(H,30,32) JXTLOXNAUILARA-UHFFFAOYSA-N 359653 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]pyridine-3-carboxamide::US10221161, Example 38::US11242333, Example 38 Plasma kallikrein Human 107 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359653&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393147 386399107 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709518 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)c4ccccc4)c3)ccc12 InChI=1S/C27H28N6O/c28-26-25-7-6-20(14-22(25)8-9-30-26)17-31-27(34)23-15-21(16-29-18-23)19-32-10-12-33(13-11-32)24-4-2-1-3-5-24/h1-9,14-16,18H,10-13,17,19H2,(H2,28,30)(H,31,34) QNILJKZWSOSWNG-UHFFFAOYSA-N 359654 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-phenylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 39::US11242333, Example 39 Plasma kallikrein Human 10000 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359654&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393150 386399108 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709519 Cc1cnn(CCOCc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1 InChI=1S/C23H24N6O2/c1-16-10-28-29(14-16)6-7-31-15-18-9-20(13-25-11-18)23(30)27-12-17-2-3-21-19(8-17)4-5-26-22(21)24/h2-5,8-11,13-14H,6-7,12,15H2,1H3,(H2,24,26)(H,27,30) AZBQFJWLTSDFIL-UHFFFAOYSA-N 359655 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(4-methylpyrazol-1-yl)ethoxy]methyl}pyridine-3-carboxamide::US10221161, Example 40::US11242333, Example 40 Plasma kallikrein Human 127 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359655&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393171 386399109 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709520 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccccc5)CC4)c3)ccc12 InChI=1S/C28H30N6O/c29-27-26-7-6-22(14-24(26)8-9-31-27)17-32-28(35)25-15-23(16-30-18-25)20-34-12-10-33(11-13-34)19-21-4-2-1-3-5-21/h1-9,14-16,18H,10-13,17,19-20H2,(H2,29,31)(H,32,35) RIFRFZVMRBBMED-UHFFFAOYSA-N 359656 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-benzylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 41::US11242333, Example 41 Plasma kallikrein Human 2750 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359656&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393218 386399110 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709521 COc1ccccc1CN1CCN(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)CC1 InChI=1S/C29H32N6O2/c1-37-27-5-3-2-4-24(27)20-35-12-10-34(11-13-35)19-22-15-25(18-31-16-22)29(36)33-17-21-6-7-26-23(14-21)8-9-32-28(26)30/h2-9,14-16,18H,10-13,17,19-20H2,1H3,(H2,30,32)(H,33,36) UEKXUKONFSMUBQ-UHFFFAOYSA-N 359657 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(2-methoxyphenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 42::US11242333, Example 42 Plasma kallikrein Human 1830 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359657&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393165 386399111 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709522 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC5CCCC5)CC4)c3)ccc12 InChI=1S/C27H34N6O/c28-26-25-6-5-21(13-23(25)7-8-30-26)16-31-27(34)24-14-22(15-29-17-24)19-33-11-9-32(10-12-33)18-20-3-1-2-4-20/h5-8,13-15,17,20H,1-4,9-12,16,18-19H2,(H2,28,30)(H,31,34) NZUKSQPPVVBORB-UHFFFAOYSA-N 359658 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(cyclopentylmethyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 43::US11242333, Example 43 Plasma kallikrein Human 11000 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359658&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393157 386399112 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709523 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccccc5F)CC4)c3)ccc12 InChI=1S/C28H29FN6O/c29-26-4-2-1-3-23(26)19-35-11-9-34(10-12-35)18-21-14-24(17-31-15-21)28(36)33-16-20-5-6-25-22(13-20)7-8-32-27(25)30/h1-8,13-15,17H,9-12,16,18-19H2,(H2,30,32)(H,33,36) YQEBTDRANIJUMP-UHFFFAOYSA-N 359659 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(2-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 44::US11242333, Example 44 Plasma kallikrein Human 6790 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359659&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117889897 386399113 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709524 COc1ccc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)cc1 InChI=1S/C29H32N6O2/c1-37-26-5-2-21(3-6-26)19-34-10-12-35(13-11-34)20-23-15-25(18-31-16-23)29(36)33-17-22-4-7-27-24(14-22)8-9-32-28(27)30/h2-9,14-16,18H,10-13,17,19-20H2,1H3,(H2,30,32)(H,33,36) QDIVAMSJIHQKTJ-UHFFFAOYSA-N 359660 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-methoxyphenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 45 Plasma kallikrein Human 33600 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359660&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393210 386399114 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709525 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5cccc(F)c5)CC4)c3)ccc12 InChI=1S/C28H29FN6O/c29-25-3-1-2-21(14-25)18-34-8-10-35(11-9-34)19-22-13-24(17-31-15-22)28(36)33-16-20-4-5-26-23(12-20)6-7-32-27(26)30/h1-7,12-15,17H,8-11,16,18-19H2,(H2,30,32)(H,33,36) JRLYQLXPWIQWEU-UHFFFAOYSA-N 359661 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(3-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 46::US11242333, Example 46 Plasma kallikrein Human 7510 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359661&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393221 386399115 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709526 Cn1cc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)cn1 InChI=1S/C26H30N8O/c1-32-16-21(14-31-32)18-34-8-6-33(7-9-34)17-20-11-23(15-28-12-20)26(35)30-13-19-2-3-24-22(10-19)4-5-29-25(24)27/h2-5,10-12,14-16H,6-9,13,17-18H2,1H3,(H2,27,29)(H,30,35) ACNMPVADOSTEOV-UHFFFAOYSA-N 359662 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(1-methylpyrazol-4-yl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 47::US11242333, Example 47 Plasma kallikrein Human 40000 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359662&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393193 386399116 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709527 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccc(F)cc5)CC4)c3)ccc12 InChI=1S/C28H29FN6O/c29-25-4-1-20(2-5-25)18-34-9-11-35(12-10-34)19-22-14-24(17-31-15-22)28(36)33-16-21-3-6-26-23(13-21)7-8-32-27(26)30/h1-8,13-15,17H,9-12,16,18-19H2,(H2,30,32)(H,33,36) WFUMVGOBVWBOPI-UHFFFAOYSA-N 359663 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 48::US11242333, Example 48 Plasma kallikrein Human 21900 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359663&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393154 386399117 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709528 COc1cccc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)c1 InChI=1S/C29H32N6O2/c1-37-26-4-2-3-22(15-26)19-34-9-11-35(12-10-34)20-23-14-25(18-31-16-23)29(36)33-17-21-5-6-27-24(13-21)7-8-32-28(27)30/h2-8,13-16,18H,9-12,17,19-20H2,1H3,(H2,30,32)(H,33,36) ZCPQVTBQVQZWBJ-UHFFFAOYSA-N 359664 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(3-methoxyphenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 49::US11242333, Example 49 Plasma kallikrein Human 6990 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359664&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393176 386399118 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709529 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CCCc5ccccc5)CC4)c3)ccc12 InChI=1S/C30H34N6O/c31-29-28-9-8-24(17-26(28)10-11-33-29)20-34-30(37)27-18-25(19-32-21-27)22-36-15-13-35(14-16-36)12-4-7-23-5-2-1-3-6-23/h1-3,5-6,8-11,17-19,21H,4,7,12-16,20,22H2,(H2,31,33)(H,34,37) WZRBBDWAJNKRJJ-UHFFFAOYSA-N 359665 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(3-phenylpropyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 50::US11242333, Example 50 Plasma kallikrein Human 10000 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359665&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393207 386399119 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709530 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CCc5ccccc5)CC4)c3)ccc12 InChI=1S/C29H32N6O/c30-28-27-7-6-23(16-25(27)8-10-32-28)19-33-29(36)26-17-24(18-31-20-26)21-35-14-12-34(13-15-35)11-9-22-4-2-1-3-5-22/h1-8,10,16-18,20H,9,11-15,19,21H2,(H2,30,32)(H,33,36) WOKOXMNRFZLCOD-UHFFFAOYSA-N 359666 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(2-phenylethyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 51::US11242333, Example 51 Plasma kallikrein Human 8110 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359666&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393152 386399120 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709531 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC(O)=O)CC4)c3)ccc12 InChI=1S/C23H26N6O3/c24-22-20-2-1-16(9-18(20)3-4-26-22)12-27-23(32)19-10-17(11-25-13-19)14-28-5-7-29(8-6-28)15-21(30)31/h1-4,9-11,13H,5-8,12,14-15H2,(H2,24,26)(H,27,32)(H,30,31) FCGIVIRGUFMPIA-UHFFFAOYSA-N 359667 US10221161, Example 52::US11242333, Example 52::{4-[(5-{[(1-Aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-yl)methyl]piperazin-1-yl}acetic acid Plasma kallikrein Human 10000 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359667&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393192 386399121 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709532 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4=O)c3)ccc12 InChI=1S/C26H24N6O2/c27-25-22-5-3-18(11-20(22)7-8-29-25)15-31-26(34)21-12-19(13-28-16-21)10-17-4-6-23(30-14-17)32-9-1-2-24(32)33/h3-8,11-14,16H,1-2,9-10,15H2,(H2,27,29)(H,31,34) FGWAAFZCRVTFKI-UHFFFAOYSA-N 359668 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2-oxopyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 53::US11242333, Example 53 Plasma kallikrein Human 200 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359668&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393215 386399122 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709533 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(F)nc4)c3)ccc12 InChI=1S/C22H18FN5O/c23-20-4-2-14(11-27-20)7-16-9-18(13-25-10-16)22(29)28-12-15-1-3-19-17(8-15)5-6-26-21(19)24/h1-6,8-11,13H,7,12H2,(H2,24,26)(H,28,29) MNWMUSUGAZXLAF-UHFFFAOYSA-N 359669 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(6-fluoropyridin-3-yl)methyl]pyridine-3-carboxamide::US10221161, Example 54::US11242333, Example 54 Plasma kallikrein Human 14600 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359669&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393149 386399123 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709534 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4)c3)ccc12 InChI=1S/C26H26N6O/c27-25-23-5-3-19(12-21(23)7-8-29-25)16-31-26(33)22-13-20(14-28-17-22)11-18-4-6-24(30-15-18)32-9-1-2-10-32/h3-8,12-15,17H,1-2,9-11,16H2,(H2,27,29)(H,31,33) YHNLOIFSKXIOLI-UHFFFAOYSA-N 359670 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(pyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 55::US11242333, Example 55 Plasma kallikrein Human 103 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359670&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393159 386399124 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709535 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCCC4)c3)ccc12 InChI=1S/C27H28N6O/c28-26-24-6-4-20(13-22(24)8-9-30-26)17-32-27(34)23-14-21(15-29-18-23)12-19-5-7-25(31-16-19)33-10-2-1-3-11-33/h4-9,13-16,18H,1-3,10-12,17H2,(H2,28,30)(H,32,34) HSRMSOFBIDEBQY-UHFFFAOYSA-N 359671 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(piperidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 56::US11242333, Example 56 Plasma kallikrein Human 313 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359671&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393162 386399125 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709536 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(F)(F)C4)c3)ccc12 InChI=1S/C26H24F2N6O/c27-26(28)6-8-34(16-26)23-4-2-17(13-32-23)9-19-11-21(15-30-12-19)25(35)33-14-18-1-3-22-20(10-18)5-7-31-24(22)29/h1-5,7,10-13,15H,6,8-9,14,16H2,(H2,29,31)(H,33,35) SQHRXWHUJDTTGU-UHFFFAOYSA-N 359672 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3,3-difluoropyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 57::US11242333, Example 57 Plasma kallikrein Human 240 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359672&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393204 386399126 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709537 CC1CCCN1c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C27H28N6O/c1-18-3-2-10-33(18)25-7-5-19(15-31-25)11-21-13-23(17-29-14-21)27(34)32-16-20-4-6-24-22(12-20)8-9-30-26(24)28/h4-9,12-15,17-18H,2-3,10-11,16H2,1H3,(H2,28,30)(H,32,34) HCKCTEYBXXLMKG-UHFFFAOYSA-N 359673 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2-methylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 58::US11242333, Example 58 Plasma kallikrein Human 153 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359673&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393156 386399127 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709538 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(O)C4)c3)ccc12 InChI=1S/C26H26N6O2/c27-25-23-3-1-18(10-20(23)5-7-29-25)14-31-26(34)21-11-19(12-28-15-21)9-17-2-4-24(30-13-17)32-8-6-22(33)16-32/h1-5,7,10-13,15,22,33H,6,8-9,14,16H2,(H2,27,29)(H,31,34) WRPGPMLIUGFQRG-UHFFFAOYSA-N 359674 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-hydroxypyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 59::US11242333, Example 59 Plasma kallikrein Human 417 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359674&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393196 386399128 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709539 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(F)C4)c3)ccc12 InChI=1S/C26H25FN6O/c27-22-6-8-33(16-22)24-4-2-17(13-31-24)9-19-11-21(15-29-12-19)26(34)32-14-18-1-3-23-20(10-18)5-7-30-25(23)28/h1-5,7,10-13,15,22H,6,8-9,14,16H2,(H2,28,30)(H,32,34) ADLMVMMMJBJZMR-UHFFFAOYSA-N 359675 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-fluoropyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 60::US11242333, Example 60 Plasma kallikrein Human 137 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359675&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393183 386399129 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709540 CC1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C27H28N6O/c1-18-7-9-33(17-18)25-5-3-19(14-31-25)10-21-12-23(16-29-13-21)27(34)32-15-20-2-4-24-22(11-20)6-8-30-26(24)28/h2-6,8,11-14,16,18H,7,9-10,15,17H2,1H3,(H2,28,30)(H,32,34) ALWCYCHCLNSCIN-UHFFFAOYSA-N 359676 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-methylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 61::US11242333, Example 61 Plasma kallikrein Human 137 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359676&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393187 386399130 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709541 COC1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C27H28N6O2/c1-35-23-7-9-33(17-23)25-5-3-18(14-31-25)10-20-12-22(16-29-13-20)27(34)32-15-19-2-4-24-21(11-19)6-8-30-26(24)28/h2-6,8,11-14,16,23H,7,9-10,15,17H2,1H3,(H2,28,30)(H,32,34) QKSNHFIMZOACNT-UHFFFAOYSA-N 359677 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-methoxypyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 62::US11242333, Example 62 Plasma kallikrein Human 255 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359677&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393214 386399131 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709542 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCOCC4)c3)ccc12 InChI=1S/C26H26N6O2/c27-25-23-3-1-19(12-21(23)5-6-29-25)16-31-26(33)22-13-20(14-28-17-22)11-18-2-4-24(30-15-18)32-7-9-34-10-8-32/h1-6,12-15,17H,7-11,16H2,(H2,27,29)(H,31,33) GCDCEQPKZBSJCH-UHFFFAOYSA-N 359678 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(morpholin-4-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 63::US11242333, Example 63 Plasma kallikrein Human 432 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359678&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393185 386399132 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709543 CN1CCN(CC1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C27H29N7O/c1-33-8-10-34(11-9-33)25-5-3-19(16-31-25)12-21-14-23(18-29-15-21)27(35)32-17-20-2-4-24-22(13-20)6-7-30-26(24)28/h2-7,13-16,18H,8-12,17H2,1H3,(H2,28,30)(H,32,35) AYIZOVVOLGYDQH-UHFFFAOYSA-N 359679 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(4-methylpiperazin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 64::US11242333, Example 64 Plasma kallikrein Human 610 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359679&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393166 386399133 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709544 CC1(C)CCCN1c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C28H30N6O/c1-28(2)9-3-11-34(28)25-7-5-19(16-32-25)12-21-14-23(18-30-15-21)27(35)33-17-20-4-6-24-22(13-20)8-10-31-26(24)29/h4-8,10,13-16,18H,3,9,11-12,17H2,1-2H3,(H2,29,31)(H,33,35) NUHVLIFKBURDJA-UHFFFAOYSA-N 359680 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2,2-dimethylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 65::US11242333, Example 65 Plasma kallikrein Human 131 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359680&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393179 386399134 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709545 CCN(CC)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C26H28N6O/c1-3-32(4-2)24-8-6-18(15-30-24)11-20-13-22(17-28-14-20)26(33)31-16-19-5-7-23-21(12-19)9-10-29-25(23)27/h5-10,12-15,17H,3-4,11,16H2,1-2H3,(H2,27,29)(H,31,33) RRHDPDBRJHCVGS-UHFFFAOYSA-N 359681 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(diethylamino)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 66 Plasma kallikrein Human 52.7 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359681&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393197 386399135 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709546 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4CO)c3)ccc12 InChI=1S/C27H28N6O2/c28-26-24-5-3-19(11-21(24)7-8-30-26)15-32-27(35)22-12-20(13-29-16-22)10-18-4-6-25(31-14-18)33-9-1-2-23(33)17-34/h3-8,11-14,16,23,34H,1-2,9-10,15,17H2,(H2,28,30)(H,32,35) CDKBTMZPQXYCQA-UHFFFAOYSA-N 359682 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[2-(hydroxymethyl)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 67::US11242333, Example 67 Plasma kallikrein Human 73.3 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359682&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393174 386399136 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709547 CN(C)C1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C28H31N7O/c1-34(2)24-8-10-35(18-24)26-6-4-19(15-32-26)11-21-13-23(17-30-14-21)28(36)33-16-20-3-5-25-22(12-20)7-9-31-27(25)29/h3-7,9,12-15,17,24H,8,10-11,16,18H2,1-2H3,(H2,29,31)(H,33,36) SPGWHUUKFWWSEI-UHFFFAOYSA-N 359683 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 68::US10221161, Example 69 Plasma kallikrein Human 375 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393169 386399137 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709548 CN(C)C1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C28H31N7O/c1-34(2)24-8-10-35(18-24)26-6-4-19(15-32-26)11-21-13-23(17-30-14-21)28(36)33-16-20-3-5-25-22(12-20)7-9-31-27(25)29/h3-7,9,12-15,17,24H,8,10-11,16,18H2,1-2H3,(H2,29,31)(H,33,36) SPGWHUUKFWWSEI-UHFFFAOYSA-N 359683 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 68::US10221161, Example 69 Plasma kallikrein Human 579 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359683&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393169 386399137 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709549 CC(C)Oc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C25H25N5O2/c1-16(2)32-23-6-4-17(13-29-23)9-19-11-21(15-27-12-19)25(31)30-14-18-3-5-22-20(10-18)7-8-28-24(22)26/h3-8,10-13,15-16H,9,14H2,1-2H3,(H2,26,28)(H,30,31) YKHQYVOPIDSSDX-UHFFFAOYSA-N 359686 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(6-isopropoxypyridin-3-yl)methyl]pyridine-3-carboxamide::US10221161, Example 70::US11242333, Example 70 Plasma kallikrein Human 1740 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359686&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393155 386399139 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709550 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(CO)C4)c3)ccc12 InChI=1S/C27H28N6O2/c28-26-24-3-1-19(10-22(24)5-7-30-26)14-32-27(35)23-11-21(12-29-15-23)9-18-2-4-25(31-13-18)33-8-6-20(16-33)17-34/h1-5,7,10-13,15,20,34H,6,8-9,14,16-17H2,(H2,28,30)(H,32,35) YHDQKRLULDVQCF-UHFFFAOYSA-N 359687 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 71::US11242333, Example 71 Plasma kallikrein Human 306 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359687&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393164 386399140 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709551 CCOC(=O)C1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C29H30N6O3/c1-2-38-29(37)23-8-10-35(18-23)26-6-4-19(15-33-26)11-21-13-24(17-31-14-21)28(36)34-16-20-3-5-25-22(12-20)7-9-32-27(25)30/h3-7,9,12-15,17,23H,2,8,10-11,16,18H2,1H3,(H2,30,32)(H,34,36) JLRATSDYYSCALN-UHFFFAOYSA-N 359688 Ethyl 1-{5-[(5-{[(1-aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-yl)methyl]pyridin-2-yl}pyrrolidine-3-carboxylate::US10221161, Example 72 Plasma kallikrein Human 860 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359688&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393190 386399141 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709552 CC(C)N(C)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C26H28N6O/c1-17(2)32(3)24-7-5-18(14-30-24)10-20-12-22(16-28-13-20)26(33)31-15-19-4-6-23-21(11-19)8-9-29-25(23)27/h4-9,11-14,16-17H,10,15H2,1-3H3,(H2,27,29)(H,31,33) QHAUWEJXKZUUPP-UHFFFAOYSA-N 359689 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[isopropyl(methyl)amino]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 73::US11242333, Example 73 Plasma kallikrein Human 51.1 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359689&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393184 386399142 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709553 CC1(C)CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C28H30N6O/c1-28(2)8-10-34(18-28)25-6-4-19(15-32-25)11-21-13-23(17-30-14-21)27(35)33-16-20-3-5-24-22(12-20)7-9-31-26(24)29/h3-7,9,12-15,17H,8,10-11,16,18H2,1-2H3,(H2,29,31)(H,33,35) ZLDDWJIJDXHGIU-UHFFFAOYSA-N 359692 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3,3-dimethylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 74::US11242333, Example 74 Plasma kallikrein Human 83.1 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359692&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393206 386399145 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709554 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(C4)C(O)=O)c3)ccc12 InChI=1S/C27H26N6O3/c28-25-23-3-1-18(10-20(23)5-7-30-25)14-32-26(34)22-11-19(12-29-15-22)9-17-2-4-24(31-13-17)33-8-6-21(16-33)27(35)36/h1-5,7,10-13,15,21H,6,8-9,14,16H2,(H2,28,30)(H,32,34)(H,35,36) SAVRWXYQJVOYRM-UHFFFAOYSA-N 359693 1-{5-[(5-{[(1-Aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-yl)methyl]pyridin-2-yl}pyrrolidine-3-carboxylic acid::US10221161, Example 75::US11242333, Example 75 Plasma kallikrein Human 6120 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359693&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393191 386399146 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709555 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4=O)c3)ccc12 InChI=1S/C26H24N6O2/c27-25-22-4-3-18(11-20(22)6-8-30-25)15-31-26(34)21-12-19(14-28-16-21)10-17-5-7-29-23(13-17)32-9-1-2-24(32)33/h3-8,11-14,16H,1-2,9-10,15H2,(H2,27,30)(H,31,34) DWTKEQLXPBZTEF-UHFFFAOYSA-N 359694 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2-oxopyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 76::US11242333, Example 76 Plasma kallikrein Human 242 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359694&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393217 386399147 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709556 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4)c3)ccc12 InChI=1S/C26H26N6O/c27-25-23-4-3-19(12-21(23)6-8-30-25)16-31-26(33)22-13-20(15-28-17-22)11-18-5-7-29-24(14-18)32-9-1-2-10-32/h3-8,12-15,17H,1-2,9-11,16H2,(H2,27,30)(H,31,33) OKYNKPFZSOLVQE-UHFFFAOYSA-N 359695 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(pyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 77::US11242333, Example 77 Plasma kallikrein Human 37.7 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359695&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117890050 386399148 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709557 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCCC4)c3)ccc12 InChI=1S/C27H28N6O/c28-26-24-5-4-20(13-22(24)7-9-31-26)17-32-27(34)23-14-21(16-29-18-23)12-19-6-8-30-25(15-19)33-10-2-1-3-11-33/h4-9,13-16,18H,1-3,10-12,17H2,(H2,28,31)(H,32,34) RJFGZABUVYSVKX-UHFFFAOYSA-N 359696 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(piperidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 78::US11242333, Example 78 Plasma kallikrein Human 164 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359696&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393189 386399149 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709558 CC1CCCN1c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C27H28N6O/c1-18-3-2-10-33(18)25-14-19(6-8-30-25)11-21-13-23(17-29-15-21)27(34)32-16-20-4-5-24-22(12-20)7-9-31-26(24)28/h4-9,12-15,17-18H,2-3,10-11,16H2,1H3,(H2,28,31)(H,32,34) QJOGYBUMALCINT-UHFFFAOYSA-N 359697 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2-methylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 79::US11242333, Example 79 Plasma kallikrein Human 155 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359697&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393170 386399150 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709559 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(F)(F)C4)c3)ccc12 InChI=1S/C26H24F2N6O/c27-26(28)5-8-34(16-26)23-12-17(3-6-31-23)9-19-11-21(15-30-13-19)25(35)33-14-18-1-2-22-20(10-18)4-7-32-24(22)29/h1-4,6-7,10-13,15H,5,8-9,14,16H2,(H2,29,32)(H,33,35) OTPILUCJJKOWPU-UHFFFAOYSA-N 359698 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3,3-difluoropyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 80::US11242333, Example 80 Plasma kallikrein Human 88.5 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359698&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393213 386399151 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709560 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(O)C4)c3)ccc12 InChI=1S/C26H26N6O2/c27-25-23-2-1-18(10-20(23)4-7-30-25)14-31-26(34)21-11-19(13-28-15-21)9-17-3-6-29-24(12-17)32-8-5-22(33)16-32/h1-4,6-7,10-13,15,22,33H,5,8-9,14,16H2,(H2,27,30)(H,31,34) PSHMRDARMQOLRC-UHFFFAOYSA-N 359699 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-hydroxypyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 81::US11242333, Example 81 Plasma kallikrein Human 674 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359699&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393153 386399152 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709561 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(F)C4)c3)ccc12 InChI=1S/C26H25FN6O/c27-22-5-8-33(16-22)24-12-17(3-6-30-24)9-19-11-21(15-29-13-19)26(34)32-14-18-1-2-23-20(10-18)4-7-31-25(23)28/h1-4,6-7,10-13,15,22H,5,8-9,14,16H2,(H2,28,31)(H,32,34) UOVPCOMKDUSQBG-UHFFFAOYSA-N 359700 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-fluoropyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 82::US11242333, Example 82 Plasma kallikrein Human 67.8 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359700&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393198 386399153 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709562 CC1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C27H28N6O/c1-18-6-9-33(17-18)25-13-19(4-7-30-25)10-21-12-23(16-29-14-21)27(34)32-15-20-2-3-24-22(11-20)5-8-31-26(24)28/h2-5,7-8,11-14,16,18H,6,9-10,15,17H2,1H3,(H2,28,31)(H,32,34) BDDHAZOVAFLCQY-UHFFFAOYSA-N 359701 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-methylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 83::US11242333, Example 83 Plasma kallikrein Human 106 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359701&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393220 386399154 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709563 CC1(C)CCCN1c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C28H30N6O/c1-28(2)8-3-11-34(28)25-15-19(6-9-31-25)12-21-14-23(18-30-16-21)27(35)33-17-20-4-5-24-22(13-20)7-10-32-26(24)29/h4-7,9-10,13-16,18H,3,8,11-12,17H2,1-2H3,(H2,29,32)(H,33,35) UUAUDGVZIJLYSI-UHFFFAOYSA-N 359702 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2,2-dimethylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 84::US11242333, Example 84 Plasma kallikrein Human 683 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359702&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393211 386399155 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709564 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCOCC4)c3)ccc12 InChI=1S/C26H26N6O2/c27-25-23-2-1-19(12-21(23)4-6-30-25)16-31-26(33)22-13-20(15-28-17-22)11-18-3-5-29-24(14-18)32-7-9-34-10-8-32/h1-6,12-15,17H,7-11,16H2,(H2,27,30)(H,31,33) WDTKDHOKUXYDRS-UHFFFAOYSA-N 359703 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(morpholin-4-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 85::US11242333, Example 85 Plasma kallikrein Human 1670 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359703&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393148 386399156 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709565 CN1CCN(CC1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C27H29N7O/c1-33-8-10-34(11-9-33)25-15-19(4-6-30-25)12-21-14-23(18-29-16-21)27(35)32-17-20-2-3-24-22(13-20)5-7-31-26(24)28/h2-7,13-16,18H,8-12,17H2,1H3,(H2,28,31)(H,32,35) CCWAWYXGGKGFJT-UHFFFAOYSA-N 359704 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(4-methylpiperazin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 86::US11242333, Example 86 Plasma kallikrein Human 395 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359704&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393188 386399157 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709566 CCN(CC)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C26H28N6O/c1-3-32(4-2)24-14-18(7-9-29-24)11-20-13-22(17-28-15-20)26(33)31-16-19-5-6-23-21(12-19)8-10-30-25(23)27/h5-10,12-15,17H,3-4,11,16H2,1-2H3,(H2,27,30)(H,31,33) BSYLXGAPHBOLPP-UHFFFAOYSA-N 359705 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(diethylamino)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 87::US11242333, Example 87 Plasma kallikrein Human 358 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359705&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393200 386399158 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709567 COC1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C27H28N6O2/c1-35-23-6-9-33(17-23)25-13-18(4-7-30-25)10-20-12-22(16-29-14-20)27(34)32-15-19-2-3-24-21(11-19)5-8-31-26(24)28/h2-5,7-8,11-14,16,23H,6,9-10,15,17H2,1H3,(H2,28,31)(H,32,34) AGESLAHMMMUCOA-UHFFFAOYSA-N 359706 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-methoxypyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 88::US11242333, Example 92 Plasma kallikrein Human 234 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359706&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393167 386399159 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709568 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4CO)c3)ccc12 InChI=1S/C27H28N6O2/c28-26-24-4-3-19(11-21(24)6-8-31-26)15-32-27(35)22-12-20(14-29-16-22)10-18-5-7-30-25(13-18)33-9-1-2-23(33)17-34/h3-8,11-14,16,23,34H,1-2,9-10,15,17H2,(H2,28,31)(H,32,35) YEGMXIRGBOBRED-UHFFFAOYSA-N 359707 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[2-(hydroxymethyl)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 89::US11242333, Example 89 Plasma kallikrein Human 104 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359707&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117889851 386399160 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709569 CN(C)C1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C28H31N7O/c1-34(2)24-7-10-35(18-24)26-14-19(5-8-31-26)11-21-13-23(17-30-15-21)28(36)33-16-20-3-4-25-22(12-20)6-9-32-27(25)29/h3-6,8-9,12-15,17,24H,7,10-11,16,18H2,1-2H3,(H2,29,32)(H,33,36) QLBNBADVDGUZLM-UHFFFAOYSA-N 359708 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 90::US10221161, Example 91 Plasma kallikrein Human 1550 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393168 386399161 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709570 CN(C)C1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C28H31N7O/c1-34(2)24-7-10-35(18-24)26-14-19(5-8-31-26)11-21-13-23(17-30-15-21)28(36)33-16-20-3-4-25-22(12-20)6-9-32-27(25)29/h3-6,8-9,12-15,17,24H,7,10-11,16,18H2,1-2H3,(H2,29,32)(H,33,36) QLBNBADVDGUZLM-UHFFFAOYSA-N 359708 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 90::US10221161, Example 91 Plasma kallikrein Human 1710 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359708&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393168 386399161 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709571 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(CO)C4)c3)ccc12 InChI=1S/C27H28N6O2/c28-26-24-2-1-19(10-22(24)4-7-31-26)14-32-27(35)23-11-21(13-29-15-23)9-18-3-6-30-25(12-18)33-8-5-20(16-33)17-34/h1-4,6-7,10-13,15,20,34H,5,8-9,14,16-17H2,(H2,28,31)(H,32,35) KXOHCDTXIZSUSX-UHFFFAOYSA-N 359710 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 92 Plasma kallikrein Human 355 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359710&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393201 386399162 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709572 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3ccc(CN)cc3C)cc2)c1 InChI=1S/C27H29N5O/c1-19-13-31-32(17-19)18-22-5-3-21(4-6-22)10-24-11-26(15-29-14-24)27(33)30-16-25-8-7-23(12-28)9-20(25)2/h3-9,11,13-15,17H,10,12,16,18,28H2,1-2H3,(H,30,33) JKTKKPCPPHYQER-UHFFFAOYSA-N 359711 N-{[4-(Aminomethyl)-2-methylphenyl]methyl}-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 93 Plasma kallikrein Human 14.4 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359711&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117889648 386399163 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709573 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1 InChI=1S/C28H31N5O/c1-19-13-32-33(17-19)18-23-6-4-22(5-7-23)10-25-11-26(15-30-14-25)28(34)31-16-27-20(2)8-24(12-29)9-21(27)3/h4-9,11,13-15,17H,10,12,16,18,29H2,1-3H3,(H,31,34) QWAPEEDIDSKKLU-UHFFFAOYSA-N 359712 N-{[4-(Aminomethyl)-2,6-dimethylphenyl]methyl}-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 94 Plasma kallikrein Human 7.47 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359712&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117889922 386399164 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709574 Cc1cnn(Cc2ccc(Cc3cncc(n3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1 InChI=1S/C27H30N6O/c1-18-12-31-33(16-18)17-22-6-4-21(5-7-22)10-24-13-29-15-26(32-24)27(34)30-14-25-19(2)8-23(11-28)9-20(25)3/h4-9,12-13,15-16H,10-11,14,17,28H2,1-3H3,(H,30,34) QDRGMOCPSUXWFS-UHFFFAOYSA-N 359713 N-{[4-(Aminomethyl)-2,6-dimethylphenyl]methyl}-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazine-2-carboxamide::US10221161, Example 95::US11242333, Example 95 Plasma kallikrein Human 53.6 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359713&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 117889949 386399165 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709575 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3ccc(CN)c(F)c3)cc2)c1 InChI=1S/C26H26FN5O/c1-18-12-31-32(16-18)17-20-4-2-19(3-5-20)8-22-9-24(15-29-13-22)26(33)30-14-21-6-7-23(11-28)25(27)10-21/h2-7,9-10,12-13,15-16H,8,11,14,17,28H2,1H3,(H,30,33) IZERGKYBLGUDKW-UHFFFAOYSA-N 359714 N-{[4-(Aminomethyl)-3-fluorophenyl]methyl}-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 96 Plasma kallikrein Human 365 US Patent 10.7270/Q23B62DG aid1797758 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359714 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=336&target=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359714&enzyme=Plasma+kallikrein&column=ki&startPg=0&Increment=50&submit=Search 121393212 386399166 1 MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLFSFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVDMRGVNFNVSKVSSVEECQKRCTNNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIKVLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFFTFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGVDFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRIAYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA 6O1G,6T7P Plasma kallikrein KLKB1_HUMAN P03952 A6NH96 B2R8H9 Q17RE8 Q17RE9 Q4W5C3 709576 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C28H26N6O/c1-19-13-33-34(17-19)18-21-4-2-20(3-5-21)10-23-12-25(16-30-14-23)28(35)32-15-22-6-7-26-24(11-22)8-9-31-27(26)29/h2-9,11-14,16-17H,10,15,18H2,1H3,(H2,29,31)(H,32,35) XZGMSMZMNPUQHT-UHFFFAOYSA-N 359614 N-[(1-Aminoisoquinolin-6-yl)methyl]-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 1::US11242333, Example 1 Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359614&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117889681 386399068 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709577 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3cnc4[nH]ccc4c3)cc2)c1 InChI=1S/C26H24N6O/c1-18-11-31-32(16-18)17-20-4-2-19(3-5-20)8-21-9-24(15-27-12-21)26(33)30-14-22-10-23-6-7-28-25(23)29-13-22/h2-7,9-13,15-16H,8,14,17H2,1H3,(H,28,29)(H,30,33) JJUHBFMQMARLNX-UHFFFAOYSA-N 359615 5-({4-[(4-Methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-3-carboxamide::US10221161, Example 2::US11242333, Example 2 Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359615&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117889991 386399069 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709578 Cc1cnn(Cc2ccc(Cc3ccnc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C28H26N6O/c1-19-15-33-34(17-19)18-21-4-2-20(3-5-21)12-22-8-10-30-26(14-22)28(35)32-16-23-6-7-25-24(13-23)9-11-31-27(25)29/h2-11,13-15,17H,12,16,18H2,1H3,(H2,29,31)(H,32,35) DZDSGRZPTVIORQ-UHFFFAOYSA-N 359616 N-[(1-Aminoisoquinolin-6-yl)methyl]-4-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-2-carboxamide::US10221161, Example 3::US11242333, Example 3 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359616&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117889735 386399070 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709579 Cc1cnn(Cc2ccc(Cc3ccnc(c3)C(=O)NCc3cnc4[nH]ccc4c3)cc2)c1 InChI=1S/C26H24N6O/c1-18-13-31-32(16-18)17-20-4-2-19(3-5-20)10-21-6-8-27-24(12-21)26(33)30-15-22-11-23-7-9-28-25(23)29-14-22/h2-9,11-14,16H,10,15,17H2,1H3,(H,28,29)(H,30,33) WRUWFRKMFQIBTK-UHFFFAOYSA-N 359617 4-({4-[(4-Methylpyrazol-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-2-carboxamide::US10221161, Example 4::US11242333, Example 4 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359617&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121406191 386399071 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709580 Nc1nccc2cc(CNC(=O)c3ccc(=O)n(Cc4ccc(Cn5ccccc5=O)cc4)c3)ccc12 InChI=1S/C29H25N5O3/c30-28-25-10-8-22(15-23(25)12-13-31-28)16-32-29(37)24-9-11-27(36)34(19-24)18-21-6-4-20(5-7-21)17-33-14-2-1-3-26(33)35/h1-15,19H,16-18H2,(H2,30,31)(H,32,37) UJFXLGBMZVPDMP-UHFFFAOYSA-N 359618 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-oxo-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 5::US11242333, Example 5 Kallikrein-1 Human 28900 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359618&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117907897 386399072 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709581 O=C(NCc1cnc2[nH]ccc2c1)c1ccc(=O)n(Cc2ccc(Cn3ccccc3=O)cc2)c1 InChI=1S/C27H23N5O3/c33-24-3-1-2-12-31(24)16-19-4-6-20(7-5-19)17-32-18-23(8-9-25(32)34)27(35)30-15-21-13-22-10-11-28-26(22)29-14-21/h1-14,18H,15-17H2,(H,28,29)(H,30,35) LSSBHLFUNMHFAM-UHFFFAOYSA-N 359619 6-Oxo-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)-N-{7H-pyrrolo[2,3-b]pyridin-3-ylmethyl}pyridine-3-carboxamide::US10221161, Example 6::US11242333, Example 6 Kallikrein-1 Human 27800 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359619&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117907999 386399073 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709582 Cc1cnn(Cc2ccc(cc2)C(O)c2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1 InChI=1S/C28H26N6O2/c1-18-12-33-34(16-18)17-19-2-5-21(6-3-19)26(35)23-11-24(15-30-14-23)28(36)32-13-20-4-7-25-22(10-20)8-9-31-27(25)29/h2-12,14-16,26,35H,13,17H2,1H3,(H2,29,31)(H,32,36) LJHHAYREDCAYJE-UHFFFAOYSA-N 359621 N-((1-Aminoisoquinolin-6-yl)methyl)-5-(hydroxy(4-((4-methyl-1H-pyrazol-1-yl)methyl)phenyl)methyl)nicotinamide::US10221161, Example 7::US11242333, Example 7 Kallikrein-1 Human 8020 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359621&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117890055 386399075 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709583 Cc1cnn(Cc2ccc(Cc3cc(ncn3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C27H25N7O/c1-18-13-33-34(15-18)16-20-4-2-19(3-5-20)11-23-12-25(32-17-31-23)27(35)30-14-21-6-7-24-22(10-21)8-9-29-26(24)28/h2-10,12-13,15,17H,11,14,16H2,1H3,(H2,28,29)(H,30,35) YVWZOLYJJRHVHL-UHFFFAOYSA-N 359622 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrimidine-4-carboxamide::US10221161, Example 8::US11242333, Example 8 Kallikrein-1 Human 28200 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359622&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117890488 386399076 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709584 Cc1cnn(Cc2ccc(Cc3cncc(n3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C27H25N7O/c1-18-12-32-34(16-18)17-20-4-2-19(3-5-20)11-23-14-29-15-25(33-23)27(35)31-13-21-6-7-24-22(10-21)8-9-30-26(24)28/h2-10,12,14-16H,11,13,17H2,1H3,(H2,28,30)(H,31,35) XNGKXROWONCSGX-UHFFFAOYSA-N 359623 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazine-2-carboxamide::US10221161, Example 9::US11242333, Example 9 Kallikrein-1 Human 5340 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359623&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117890033 386399077 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709585 Cc1ccc2cc(Cc3cncc(n3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1 InChI=1S/C26H22N6O/c1-16-2-5-20-10-17(4-7-23(20)31-16)12-21-14-28-15-24(32-21)26(33)30-13-18-3-6-22-19(11-18)8-9-29-25(22)27/h2-11,14-15H,12-13H2,1H3,(H2,27,29)(H,30,33) CGNIOLXFEPYYHB-UHFFFAOYSA-N 359624 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-[(2-methylquinolin-6-yl)methyl]pyrazine-2-carboxamide::US10221161, Example 10::US11242333, Example 10 Kallikrein-1 Human 3020 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359624&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117890082 386399078 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709586 Cc1cnn(Cc2ccc(Cc3cnnc(c3)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C27H25N7O/c1-18-13-32-34(16-18)17-20-4-2-19(3-5-20)10-22-12-25(33-31-15-22)27(35)30-14-21-6-7-24-23(11-21)8-9-29-26(24)28/h2-9,11-13,15-16H,10,14,17H2,1H3,(H2,28,29)(H,30,35) DDCNHPCNBRRWTO-UHFFFAOYSA-N 359625 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridazine-3-carboxamide::US10221161, Example 11::US11242333, Example 11 Kallikrein-1 Human 37100 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359625&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117890119 386399079 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709587 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3c(C)nc4[nH]ccc(C)c34)cc2)c1 InChI=1S/C28H28N6O/c1-18-12-32-34(16-18)17-22-6-4-21(5-7-22)10-23-11-24(14-29-13-23)28(35)31-15-25-20(3)33-27-26(25)19(2)8-9-30-27/h4-9,11-14,16H,10,15,17H2,1-3H3,(H,30,33)(H,31,35) ZBVFUONSGPAIOP-UHFFFAOYSA-N 359626 N-({2,4-Dimethyl-7H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 12 Kallikrein-1 Human 14900 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359626&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393177 386399080 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709588 Cc1nc2[nH]ccc(C)c2c1CNC(=O)c1cncc(Cc2ccc3nc(C)ccc3c2)c1 InChI=1S/C27H25N5O/c1-16-8-9-29-26-25(16)23(18(3)32-26)15-30-27(33)22-12-20(13-28-14-22)10-19-5-7-24-21(11-19)6-4-17(2)31-24/h4-9,11-14H,10,15H2,1-3H3,(H,29,32)(H,30,33) MPEZSZKUEPIWCM-UHFFFAOYSA-N 359627 N-({2,4-Dimethyl-7H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 13 Kallikrein-1 Human 236 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359627&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393186 386399081 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709589 Nc1nccc2cc(CNC(=O)c3ccc(=O)n(Cc4csc(n4)-c4ccccc4)c3)ccc12 InChI=1S/C26H21N5O2S/c27-24-22-8-6-17(12-19(22)10-11-28-24)13-29-25(33)20-7-9-23(32)31(14-20)15-21-16-34-26(30-21)18-4-2-1-3-5-18/h1-12,14,16H,13,15H2,(H2,27,28)(H,29,33) TVMQOXCUTCHUPL-UHFFFAOYSA-N 359628 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-oxo-1-[(2-phenyl-1,3-thiazol-4-yl)methyl]pyridine-3-carboxamide::US10221161, Example 14::US11242333, Example 14 Kallikrein-1 Human 4160 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359628&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393161 386399082 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709590 Cc1cnn(Cc2ccc(Cn3cc(ccc3=O)C(=O)NCc3ccc4c(N)nccc4c3)cc2)c1 InChI=1S/C28H26N6O2/c1-19-13-32-34(15-19)17-21-4-2-20(3-5-21)16-33-18-24(7-9-26(33)35)28(36)31-14-22-6-8-25-23(12-22)10-11-30-27(25)29/h2-13,15,18H,14,16-17H2,1H3,(H2,29,30)(H,31,36) JRVPVSFGNJKYLB-UHFFFAOYSA-N 359629 N-[(1-Aminoisoquinolin-6-yl)methyl]-1-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)-6-oxopyridine-3-carboxamide::US10221161, Example 15::US11242333, Example 15 Kallikrein-1 Human 17600 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359629&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117890144 386399083 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709591 Cc1ccc2cc(Cn3cc(ccc3=O)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1 InChI=1S/C27H23N5O2/c1-17-2-5-21-13-19(4-8-24(21)31-17)15-32-16-22(6-9-25(32)33)27(34)30-14-18-3-7-23-20(12-18)10-11-29-26(23)28/h2-13,16H,14-15H2,1H3,(H2,28,29)(H,30,34) VRTRGFXOHVRQQQ-UHFFFAOYSA-N 359630 N-[(1-Aminoisoquinolin-6-yl)methyl]-1-[(2-methylquinolin-6-yl)methyl]-6-oxopyridine-3-carboxamide::US10221161, Example 16::US11242333, Example 16 Kallikrein-1 Human 2060 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359630&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393202 386399084 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709592 Cc1ccc2cc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1 InChI=1S/C27H23N5O/c1-17-2-5-22-11-18(4-7-25(22)32-17)10-20-13-23(16-29-14-20)27(33)31-15-19-3-6-24-21(12-19)8-9-30-26(24)28/h2-9,11-14,16H,10,15H2,1H3,(H2,28,30)(H,31,33) YGGSTOCJVHLULA-UHFFFAOYSA-N 359631 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 17::US11242333, Example 17 Kallikrein-1 Human 1120 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359631&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117890179 386399085 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709593 COc1ncc(cc1Cc1ccc2nc(C)ccc2c1)C(=O)NCc1ccc2c(N)nccc2c1 InChI=1S/C28H25N5O2/c1-17-3-6-21-11-18(5-8-25(21)33-17)12-22-14-23(16-32-28(22)35-2)27(34)31-15-19-4-7-24-20(13-19)9-10-30-26(24)29/h3-11,13-14,16H,12,15H2,1-2H3,(H2,29,30)(H,31,34) RAXAJDWJQASKEB-UHFFFAOYSA-N 359632 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-methoxy-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 18::US11242333, Example 19 Kallikrein-1 Human 1740 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359632&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393219 386399086 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709594 COc1ncc(Cc2ccc3nc(C)ccc3c2)cc1C(=O)NCc1ccc2c(N)nccc2c1 InChI=1S/C28H25N5O2/c1-17-3-6-22-12-18(5-8-25(22)33-17)11-20-14-24(28(35-2)32-16-20)27(34)31-15-19-4-7-23-21(13-19)9-10-30-26(23)29/h3-10,12-14,16H,11,15H2,1-2H3,(H2,29,30)(H,31,34) NTARKBOIYLKMIA-UHFFFAOYSA-N 359633 N-[(1-Aminoisoquinolin-6-yl)methyl]-2-methoxy-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 19::US11242333, Example 18 Kallikrein-1 Human 1210 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359633&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393195 386399087 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709595 Cc1ccc2cc(Cc3c[nH]c(=O)c(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1 InChI=1S/C27H23N5O2/c1-16-2-5-21-11-17(4-7-24(21)32-16)10-19-13-23(27(34)31-15-19)26(33)30-14-18-3-6-22-20(12-18)8-9-29-25(22)28/h2-9,11-13,15H,10,14H2,1H3,(H2,28,29)(H,30,33)(H,31,34) BWDGDESETBEAIN-UHFFFAOYSA-N 359634 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methylquinolin-6-yl)methyl]-2-oxo-1H-pyridine-3-carboxamide::US10221161, Example 20 Kallikrein-1 Human 2490 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359634&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 139269071 386399088 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709596 CNc1ncc(cc1Cc1ccc2nc(C)ccc2c1)C(=O)NCc1ccc2c(N)nccc2c1 InChI=1S/C28H26N6O/c1-17-3-6-21-11-18(5-8-25(21)34-17)12-22-14-23(16-32-27(22)30-2)28(35)33-15-19-4-7-24-20(13-19)9-10-31-26(24)29/h3-11,13-14,16H,12,15H2,1-2H3,(H2,29,31)(H,30,32)(H,33,35) VPCARFQYWNGPJW-UHFFFAOYSA-N 359635 N-[(1-Aminoisoquinolin-6-yl)methyl]-6-(methylamino)-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 21 Kallikrein-1 Human 5990 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359635&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117889797 386399089 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709597 Cc1ccc2cc(Cc3cnc(C)c(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc2n1 InChI=1S/C28H25N5O/c1-17-3-6-23-12-19(5-8-26(23)33-17)11-21-14-25(18(2)31-16-21)28(34)32-15-20-4-7-24-22(13-20)9-10-30-27(24)29/h3-10,12-14,16H,11,15H2,1-2H3,(H2,29,30)(H,32,34) FAQUHNMIVPDPJH-UHFFFAOYSA-N 359637 N-[(1-Aminoisoquinolin-6-yl)methyl]-2-methyl-5-[(2-methylquinolin-6-yl)methyl]pyridine-3-carboxamide::US10221161, Example 22 Kallikrein-1 Human 484 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359637&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117890164 386399091 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709598 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccccc4)c3)ccc12 InChI=1S/C23H20N4O/c24-22-21-7-6-17(11-19(21)8-9-26-22)14-27-23(28)20-12-18(13-25-15-20)10-16-4-2-1-3-5-16/h1-9,11-13,15H,10,14H2,(H2,24,26)(H,27,28) HMNZKYMVBHQDLG-UHFFFAOYSA-N 359638 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-benzylpyridine-3-carboxamide::US10221161, Example 23::US11242333, Example 23 Kallikrein-1 Human 32700 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359638&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117890433 386399092 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709599 Nc1nccc2cc(CNC(=O)c3cncc(Cc4csc(n4)-c4ccccc4)c3)ccc12 InChI=1S/C26H21N5OS/c27-24-23-7-6-17(10-20(23)8-9-29-24)14-30-25(32)21-11-18(13-28-15-21)12-22-16-33-26(31-22)19-4-2-1-3-5-19/h1-11,13,15-16H,12,14H2,(H2,27,29)(H,30,32) ACVNKJMNWOONDL-UHFFFAOYSA-N 359639 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-phenyl-1,3-thiazol-4-yl)methyl]pyridine-3-carboxamide::US10221161, Example 24 Kallikrein-1 Human 4000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359639&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393158 386399093 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709600 COc1cccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1 InChI=1S/C24H22N4O2/c1-30-21-4-2-3-16(12-21)9-18-11-20(15-26-13-18)24(29)28-14-17-5-6-22-19(10-17)7-8-27-23(22)25/h2-8,10-13,15H,9,14H2,1H3,(H2,25,27)(H,28,29) NHVPFJINKKJQSZ-UHFFFAOYSA-N 359640 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(3-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 25::US11242333, Example 25 Kallikrein-1 Human 6170 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359640&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393160 386399094 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709601 COc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cc1 InChI=1S/C24H22N4O2/c1-30-21-5-2-16(3-6-21)10-18-12-20(15-26-13-18)24(29)28-14-17-4-7-22-19(11-17)8-9-27-23(22)25/h2-9,11-13,15H,10,14H2,1H3,(H2,25,27)(H,28,29) RXDWASWWHDDTEG-UHFFFAOYSA-N 359641 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 26::US11242333, Example 26 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359641&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393173 386399095 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709602 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(cc4)-n4cccn4)c3)ccc12 InChI=1S/C26H22N6O/c27-25-24-7-4-19(13-21(24)8-10-29-25)16-30-26(33)22-14-20(15-28-17-22)12-18-2-5-23(6-3-18)32-11-1-9-31-32/h1-11,13-15,17H,12,16H2,(H2,27,29)(H,30,33) MJHTYGXMZRJQOL-UHFFFAOYSA-N 359642 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(pyrazol-1-yl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 27::US11242333, Example 27 Kallikrein-1 Human 12100 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359642&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393199 386399096 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709603 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc5ccncc5c4)c3)ccc12 InChI=1S/C26H21N5O/c27-25-24-4-2-18(11-21(24)6-8-30-25)14-31-26(32)23-12-19(13-29-16-23)9-17-1-3-20-5-7-28-15-22(20)10-17/h1-8,10-13,15-16H,9,14H2,(H2,27,30)(H,31,32) QWPOIDBZQCSTHS-UHFFFAOYSA-N 359643 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-(isoquinolin-7-ylmethyl)pyridine-3-carboxamide::US10221161, Example 28::US11242333, Example 28 Kallikrein-1 Human 5900 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359643&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393146 386399097 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709604 COc1ccccc1Cc1cncc(c1)C(=O)NCc1ccc2c(N)nccc2c1 InChI=1S/C24H22N4O2/c1-30-22-5-3-2-4-19(22)11-17-12-20(15-26-13-17)24(29)28-14-16-6-7-21-18(10-16)8-9-27-23(21)25/h2-10,12-13,15H,11,14H2,1H3,(H2,25,27)(H,28,29) RJBICVKPFVWOFZ-UHFFFAOYSA-N 359644 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(2-methoxyphenyl)methyl]pyridine-3-carboxamide::US10221161, Example 29::US11242333, Example 29 Kallikrein-1 Human 7350 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359644&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393216 386399098 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709605 Nc1nccc2cc(CNC(=O)c3cncc(Cc4cccc(c4)-n4cccn4)c3)ccc12 InChI=1S/C26H22N6O/c27-25-24-6-5-19(12-21(24)7-9-29-25)16-30-26(33)22-13-20(15-28-17-22)11-18-3-1-4-23(14-18)32-10-2-8-31-32/h1-10,12-15,17H,11,16H2,(H2,27,29)(H,30,33) QCNNYPSWAPTRPO-UHFFFAOYSA-N 359645 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[3-(pyrazol-1-yl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 30::US11242333, Example 30 Kallikrein-1 Human 2850 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359645 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359645&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393194 386399099 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709606 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc5ncccc5c4)c3)ccc12 InChI=1S/C26H21N5O/c27-25-23-5-3-18(12-20(23)7-9-30-25)15-31-26(32)22-13-19(14-28-16-22)10-17-4-6-24-21(11-17)2-1-8-29-24/h1-9,11-14,16H,10,15H2,(H2,27,30)(H,31,32) XUTIWWYHRPIIGM-UHFFFAOYSA-N 359646 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-(quinolin-6-ylmethyl)pyridine-3-carboxamide::US10221161, Example 31::US11242333, Example 31 Kallikrein-1 Human 4130 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359646&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117889860 386399100 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709607 Nc1nccc2cc(CNC(=O)c3cncc(Cc4cccc(Cn5cccn5)c4)c3)ccc12 InChI=1S/C27H24N6O/c28-26-25-6-5-20(13-23(25)7-9-30-26)16-31-27(34)24-14-22(15-29-17-24)12-19-3-1-4-21(11-19)18-33-10-2-8-32-33/h1-11,13-15,17H,12,16,18H2,(H2,28,30)(H,31,34) KXHZGAGGNIYIJJ-UHFFFAOYSA-N 359647 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[3-(pyrazol-1-ylmethyl)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 32::US11242333, Example 32 Kallikrein-1 Human 9530 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359647&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393182 386399101 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709608 COc1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccc1Cn1cc(C)cn1 InChI=1S/C29H28N6O2/c1-19-13-34-35(17-19)18-24-5-3-20(12-27(24)37-2)9-22-11-25(16-31-14-22)29(36)33-15-21-4-6-26-23(10-21)7-8-32-28(26)30/h3-8,10-14,16-17H,9,15,18H2,1-2H3,(H2,30,32)(H,33,36) GTAQUAIETWGMKZ-UHFFFAOYSA-N 359648 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({3-methoxy-4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 33::US11242333, Example 33 Kallikrein-1 Human 17100 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359648 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359648&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117889845 386399102 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709609 COCCOc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cc1 InChI=1S/C26H26N4O3/c1-32-10-11-33-23-5-2-18(3-6-23)12-20-14-22(17-28-15-20)26(31)30-16-19-4-7-24-21(13-19)8-9-29-25(24)27/h2-9,13-15,17H,10-12,16H2,1H3,(H2,27,29)(H,30,31) VWAFTKDLCVIHNB-UHFFFAOYSA-N 359649 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(2-methoxyethoxy)phenyl]methyl}pyridine-3-carboxamide::US10221161, Example 34::US11242333, Example 34 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359649&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393208 386399103 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709610 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)S(=O)(=O)c4ccccc4)c3)ccc12 InChI=1S/C27H28N6O3S/c28-26-25-7-6-20(14-22(25)8-9-30-26)17-31-27(34)23-15-21(16-29-18-23)19-32-10-12-33(13-11-32)37(35,36)24-4-2-1-3-5-24/h1-9,14-16,18H,10-13,17,19H2,(H2,28,30)(H,31,34) GSABBNCJRVLTCT-UHFFFAOYSA-N 359650 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(benzenesulfonyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 35::US11242333, Example 35 Kallikrein-1 Human 29800 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359650&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393203 386399104 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709611 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)C(=O)c4ccccc4)c3)ccc12 InChI=1S/C28H28N6O2/c29-26-25-7-6-20(14-23(25)8-9-31-26)17-32-27(35)24-15-21(16-30-18-24)19-33-10-12-34(13-11-33)28(36)22-4-2-1-3-5-22/h1-9,14-16,18H,10-13,17,19H2,(H2,29,31)(H,32,35) QQISCDLIEFYLAP-UHFFFAOYSA-N 359651 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-benzoylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 36::US11242333, Example 36 Kallikrein-1 Human 23800 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359651&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393205 386399105 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709612 Cc1cnn(CC2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)c1 InChI=1S/C27H31N7O/c1-19-12-32-34(16-19)18-20-5-8-33(9-6-20)17-22-11-24(15-29-13-22)27(35)31-14-21-2-3-25-23(10-21)4-7-30-26(25)28/h2-4,7,10-13,15-16,20H,5-6,8-9,14,17-18H2,1H3,(H2,28,30)(H,31,35) HYHCEUBNRXJNAP-UHFFFAOYSA-N 359652 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-methylpyrazol-1-yl)methyl]piperidin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 37 Kallikrein-1 Human 29100 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359652&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393163 386399106 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709613 CN1CCOc2cc(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)ccc12 InChI=1S/C26H25N5O2/c1-31-8-9-33-24-13-17(3-5-23(24)31)10-19-12-21(16-28-14-19)26(32)30-15-18-2-4-22-20(11-18)6-7-29-25(22)27/h2-7,11-14,16H,8-10,15H2,1H3,(H2,27,29)(H,30,32) JXTLOXNAUILARA-UHFFFAOYSA-N 359653 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methyl]pyridine-3-carboxamide::US10221161, Example 38::US11242333, Example 38 Kallikrein-1 Human 8600 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359653&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393147 386399107 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709614 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC4)c4ccccc4)c3)ccc12 InChI=1S/C27H28N6O/c28-26-25-7-6-20(14-22(25)8-9-30-26)17-31-27(34)23-15-21(16-29-18-23)19-32-10-12-33(13-11-32)24-4-2-1-3-5-24/h1-9,14-16,18H,10-13,17,19H2,(H2,28,30)(H,31,34) QNILJKZWSOSWNG-UHFFFAOYSA-N 359654 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-phenylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 39::US11242333, Example 39 Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359654&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393150 386399108 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709615 Cc1cnn(CCOCc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)c1 InChI=1S/C23H24N6O2/c1-16-10-28-29(14-16)6-7-31-15-18-9-20(13-25-11-18)23(30)27-12-17-2-3-21-19(8-17)4-5-26-22(21)24/h2-5,8-11,13-14H,6-7,12,15H2,1H3,(H2,24,26)(H,27,30) AZBQFJWLTSDFIL-UHFFFAOYSA-N 359655 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(4-methylpyrazol-1-yl)ethoxy]methyl}pyridine-3-carboxamide::US10221161, Example 40::US11242333, Example 40 Kallikrein-1 Human 4870 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359655&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393171 386399109 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709616 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccccc5)CC4)c3)ccc12 InChI=1S/C28H30N6O/c29-27-26-7-6-22(14-24(26)8-9-31-27)17-32-28(35)25-15-23(16-30-18-25)20-34-12-10-33(11-13-34)19-21-4-2-1-3-5-21/h1-9,14-16,18H,10-13,17,19-20H2,(H2,29,31)(H,32,35) RIFRFZVMRBBMED-UHFFFAOYSA-N 359656 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(4-benzylpiperazin-1-yl)methyl]pyridine-3-carboxamide::US10221161, Example 41::US11242333, Example 41 Kallikrein-1 Human 37000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359656&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393218 386399110 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709617 COc1ccccc1CN1CCN(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)CC1 InChI=1S/C29H32N6O2/c1-37-27-5-3-2-4-24(27)20-35-12-10-34(11-13-35)19-22-15-25(18-31-16-22)29(36)33-17-21-6-7-26-23(14-21)8-9-32-28(26)30/h2-9,14-16,18H,10-13,17,19-20H2,1H3,(H2,30,32)(H,33,36) UEKXUKONFSMUBQ-UHFFFAOYSA-N 359657 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(2-methoxyphenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 42::US11242333, Example 42 Kallikrein-1 Human 24300 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359657&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393165 386399111 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709618 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC5CCCC5)CC4)c3)ccc12 InChI=1S/C27H34N6O/c28-26-25-6-5-21(13-23(25)7-8-30-26)16-31-27(34)24-14-22(15-29-17-24)19-33-11-9-32(10-12-33)18-20-3-1-2-4-20/h5-8,13-15,17,20H,1-4,9-12,16,18-19H2,(H2,28,30)(H,31,34) NZUKSQPPVVBORB-UHFFFAOYSA-N 359658 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(cyclopentylmethyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 43::US11242333, Example 43 Kallikrein-1 Human 17900 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359658&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393157 386399112 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709619 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccccc5F)CC4)c3)ccc12 InChI=1S/C28H29FN6O/c29-26-4-2-1-3-23(26)19-35-11-9-34(10-12-35)18-21-14-24(17-31-15-21)28(36)33-16-20-5-6-25-22(13-20)7-8-32-27(25)30/h1-8,13-15,17H,9-12,16,18-19H2,(H2,30,32)(H,33,36) YQEBTDRANIJUMP-UHFFFAOYSA-N 359659 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(2-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 44::US11242333, Example 44 Kallikrein-1 Human 28000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359659&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117889897 386399113 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709620 COc1ccc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)cc1 InChI=1S/C29H32N6O2/c1-37-26-5-2-21(3-6-26)19-34-10-12-35(13-11-34)20-23-15-25(18-31-16-23)29(36)33-17-22-4-7-27-24(14-22)8-9-32-28(27)30/h2-9,14-16,18H,10-13,17,19-20H2,1H3,(H2,30,32)(H,33,36) QDIVAMSJIHQKTJ-UHFFFAOYSA-N 359660 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-methoxyphenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 45 Kallikrein-1 Human 26900 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359660&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393210 386399114 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709621 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5cccc(F)c5)CC4)c3)ccc12 InChI=1S/C28H29FN6O/c29-25-3-1-2-21(14-25)18-34-8-10-35(11-9-34)19-22-13-24(17-31-15-22)28(36)33-16-20-4-5-26-23(12-20)6-7-32-27(26)30/h1-7,12-15,17H,8-11,16,18-19H2,(H2,30,32)(H,33,36) JRLYQLXPWIQWEU-UHFFFAOYSA-N 359661 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(3-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 46::US11242333, Example 46 Kallikrein-1 Human 29200 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359661&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393221 386399115 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709622 Cn1cc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)cn1 InChI=1S/C26H30N8O/c1-32-16-21(14-31-32)18-34-8-6-33(7-9-34)17-20-11-23(15-28-12-20)26(35)30-13-19-2-3-24-22(10-19)4-5-29-25(24)27/h2-5,10-12,14-16H,6-9,13,17-18H2,1H3,(H2,27,29)(H,30,35) ACNMPVADOSTEOV-UHFFFAOYSA-N 359662 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(1-methylpyrazol-4-yl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 47::US11242333, Example 47 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359662&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393193 386399116 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709623 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(Cc5ccc(F)cc5)CC4)c3)ccc12 InChI=1S/C28H29FN6O/c29-25-4-1-20(2-5-25)18-34-9-11-35(12-10-34)19-22-14-24(17-31-15-22)28(36)33-16-21-3-6-26-23(13-21)7-8-32-27(26)30/h1-8,13-15,17H,9-12,16,18-19H2,(H2,30,32)(H,33,36) WFUMVGOBVWBOPI-UHFFFAOYSA-N 359663 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(4-fluorophenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 48::US11242333, Example 48 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359663&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393154 386399117 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709624 COc1cccc(CN2CCN(Cc3cncc(c3)C(=O)NCc3ccc4c(N)nccc4c3)CC2)c1 InChI=1S/C29H32N6O2/c1-37-26-4-2-3-22(15-26)19-34-9-11-35(12-10-34)20-23-14-25(18-31-16-23)29(36)33-17-21-5-6-27-24(13-21)7-8-32-28(27)30/h2-8,13-16,18H,9-12,17,19-20H2,1H3,(H2,30,32)(H,33,36) ZCPQVTBQVQZWBJ-UHFFFAOYSA-N 359664 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({4-[(3-methoxyphenyl)methyl]piperazin-1-yl}methyl)pyridine-3-carboxamide::US10221161, Example 49::US11242333, Example 49 Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359664&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393176 386399118 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709625 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CCCc5ccccc5)CC4)c3)ccc12 InChI=1S/C30H34N6O/c31-29-28-9-8-24(17-26(28)10-11-33-29)20-34-30(37)27-18-25(19-32-21-27)22-36-15-13-35(14-16-36)12-4-7-23-5-2-1-3-6-23/h1-3,5-6,8-11,17-19,21H,4,7,12-16,20,22H2,(H2,31,33)(H,34,37) WZRBBDWAJNKRJJ-UHFFFAOYSA-N 359665 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(3-phenylpropyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 50::US11242333, Example 50 Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359665&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393207 386399119 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709626 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CCc5ccccc5)CC4)c3)ccc12 InChI=1S/C29H32N6O/c30-28-27-7-6-23(16-25(27)8-10-32-28)19-33-29(36)26-17-24(18-31-20-26)21-35-14-12-34(13-15-35)11-9-22-4-2-1-3-5-22/h1-8,10,16-18,20H,9,11-15,19,21H2,(H2,30,32)(H,33,36) WOKOXMNRFZLCOD-UHFFFAOYSA-N 359666 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[4-(2-phenylethyl)piperazin-1-yl]methyl}pyridine-3-carboxamide::US10221161, Example 51::US11242333, Example 51 Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359666&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393152 386399120 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709627 Nc1nccc2cc(CNC(=O)c3cncc(CN4CCN(CC(O)=O)CC4)c3)ccc12 InChI=1S/C23H26N6O3/c24-22-20-2-1-16(9-18(20)3-4-26-22)12-27-23(32)19-10-17(11-25-13-19)14-28-5-7-29(8-6-28)15-21(30)31/h1-4,9-11,13H,5-8,12,14-15H2,(H2,24,26)(H,27,32)(H,30,31) FCGIVIRGUFMPIA-UHFFFAOYSA-N 359667 US10221161, Example 52::US11242333, Example 52::{4-[(5-{[(1-Aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-yl)methyl]piperazin-1-yl}acetic acid Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359667&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393192 386399121 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709628 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4=O)c3)ccc12 InChI=1S/C26H24N6O2/c27-25-22-5-3-18(11-20(22)7-8-29-25)15-31-26(34)21-12-19(13-28-16-21)10-17-4-6-23(30-14-17)32-9-1-2-24(32)33/h3-8,11-14,16H,1-2,9-10,15H2,(H2,27,29)(H,31,34) FGWAAFZCRVTFKI-UHFFFAOYSA-N 359668 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2-oxopyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 53::US11242333, Example 53 Kallikrein-1 Human 3860 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359668&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393215 386399122 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709629 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(F)nc4)c3)ccc12 InChI=1S/C22H18FN5O/c23-20-4-2-14(11-27-20)7-16-9-18(13-25-10-16)22(29)28-12-15-1-3-19-17(8-15)5-6-26-21(19)24/h1-6,8-11,13H,7,12H2,(H2,24,26)(H,28,29) MNWMUSUGAZXLAF-UHFFFAOYSA-N 359669 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(6-fluoropyridin-3-yl)methyl]pyridine-3-carboxamide::US10221161, Example 54::US11242333, Example 54 Kallikrein-1 Human 10700 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359669&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393149 386399123 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709630 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4)c3)ccc12 InChI=1S/C26H26N6O/c27-25-23-5-3-19(12-21(23)7-8-29-25)16-31-26(33)22-13-20(14-28-17-22)11-18-4-6-24(30-15-18)32-9-1-2-10-32/h3-8,12-15,17H,1-2,9-11,16H2,(H2,27,29)(H,31,33) YHNLOIFSKXIOLI-UHFFFAOYSA-N 359670 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(pyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 55::US11242333, Example 55 Kallikrein-1 Human 4960 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359670&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393159 386399124 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709631 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCCC4)c3)ccc12 InChI=1S/C27H28N6O/c28-26-24-6-4-20(13-22(24)8-9-30-26)17-32-27(34)23-14-21(15-29-18-23)12-19-5-7-25(31-16-19)33-10-2-1-3-11-33/h4-9,13-16,18H,1-3,10-12,17H2,(H2,28,30)(H,32,34) HSRMSOFBIDEBQY-UHFFFAOYSA-N 359671 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(piperidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 56::US11242333, Example 56 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359671&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393162 386399125 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709632 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(F)(F)C4)c3)ccc12 InChI=1S/C26H24F2N6O/c27-26(28)6-8-34(16-26)23-4-2-17(13-32-23)9-19-11-21(15-30-12-19)25(35)33-14-18-1-3-22-20(10-18)5-7-31-24(22)29/h1-5,7,10-13,15H,6,8-9,14,16H2,(H2,29,31)(H,33,35) SQHRXWHUJDTTGU-UHFFFAOYSA-N 359672 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3,3-difluoropyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 57::US11242333, Example 57 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359672&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393204 386399126 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709633 CC1CCCN1c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C27H28N6O/c1-18-3-2-10-33(18)25-7-5-19(15-31-25)11-21-13-23(17-29-14-21)27(34)32-16-20-4-6-24-22(12-20)8-9-30-26(24)28/h4-9,12-15,17-18H,2-3,10-11,16H2,1H3,(H2,28,30)(H,32,34) HCKCTEYBXXLMKG-UHFFFAOYSA-N 359673 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2-methylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 58::US11242333, Example 58 Kallikrein-1 Human 6520 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359673 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359673&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393156 386399127 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709634 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(O)C4)c3)ccc12 InChI=1S/C26H26N6O2/c27-25-23-3-1-18(10-20(23)5-7-29-25)14-31-26(34)21-11-19(12-28-15-21)9-17-2-4-24(30-13-17)32-8-6-22(33)16-32/h1-5,7,10-13,15,22,33H,6,8-9,14,16H2,(H2,27,29)(H,31,34) WRPGPMLIUGFQRG-UHFFFAOYSA-N 359674 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-hydroxypyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 59::US11242333, Example 59 Kallikrein-1 Human 6010 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359674 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359674&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393196 386399128 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709635 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(F)C4)c3)ccc12 InChI=1S/C26H25FN6O/c27-22-6-8-33(16-22)24-4-2-17(13-31-24)9-19-11-21(15-29-12-19)26(34)32-14-18-1-3-23-20(10-18)5-7-30-25(23)28/h1-5,7,10-13,15,22H,6,8-9,14,16H2,(H2,28,30)(H,32,34) ADLMVMMMJBJZMR-UHFFFAOYSA-N 359675 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-fluoropyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 60::US11242333, Example 60 Kallikrein-1 Human 8690 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359675&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393183 386399129 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709636 CC1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C27H28N6O/c1-18-7-9-33(17-18)25-5-3-19(14-31-25)10-21-12-23(16-29-13-21)27(34)32-15-20-2-4-24-22(11-20)6-8-30-26(24)28/h2-6,8,11-14,16,18H,7,9-10,15,17H2,1H3,(H2,28,30)(H,32,34) ALWCYCHCLNSCIN-UHFFFAOYSA-N 359676 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-methylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 61::US11242333, Example 61 Kallikrein-1 Human 6550 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359676&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393187 386399130 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709637 COC1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C27H28N6O2/c1-35-23-7-9-33(17-23)25-5-3-18(14-31-25)10-20-12-22(16-29-13-20)27(34)32-15-19-2-4-24-21(11-19)6-8-30-26(24)28/h2-6,8,11-14,16,23H,7,9-10,15,17H2,1H3,(H2,28,30)(H,32,34) QKSNHFIMZOACNT-UHFFFAOYSA-N 359677 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3-methoxypyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 62::US11242333, Example 62 Kallikrein-1 Human 8890 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359677&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393214 386399131 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709638 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCOCC4)c3)ccc12 InChI=1S/C26H26N6O2/c27-25-23-3-1-19(12-21(23)5-6-29-25)16-31-26(33)22-13-20(14-28-17-22)11-18-2-4-24(30-15-18)32-7-9-34-10-8-32/h1-6,12-15,17H,7-11,16H2,(H2,27,29)(H,31,33) GCDCEQPKZBSJCH-UHFFFAOYSA-N 359678 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(morpholin-4-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 63::US11242333, Example 63 Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359678&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393185 386399132 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709639 CN1CCN(CC1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C27H29N7O/c1-33-8-10-34(11-9-33)25-5-3-19(16-31-25)12-21-14-23(18-29-15-21)27(35)32-17-20-2-4-24-22(13-20)6-7-30-26(24)28/h2-7,13-16,18H,8-12,17H2,1H3,(H2,28,30)(H,32,35) AYIZOVVOLGYDQH-UHFFFAOYSA-N 359679 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(4-methylpiperazin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 64::US11242333, Example 64 Kallikrein-1 Human 5340 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359679&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393166 386399133 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709640 CC1(C)CCCN1c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C28H30N6O/c1-28(2)9-3-11-34(28)25-7-5-19(16-32-25)12-21-14-23(18-30-15-21)27(35)33-17-20-4-6-24-22(13-20)8-10-31-26(24)29/h4-8,10,13-16,18H,3,9,11-12,17H2,1-2H3,(H2,29,31)(H,33,35) NUHVLIFKBURDJA-UHFFFAOYSA-N 359680 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(2,2-dimethylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 65::US11242333, Example 65 Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359680&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393179 386399134 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709641 CCN(CC)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C26H28N6O/c1-3-32(4-2)24-8-6-18(15-30-24)11-20-13-22(17-28-14-20)26(33)31-16-19-5-7-23-21(12-19)9-10-29-25(23)27/h5-10,12-15,17H,3-4,11,16H2,1-2H3,(H2,27,29)(H,31,33) RRHDPDBRJHCVGS-UHFFFAOYSA-N 359681 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(diethylamino)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 66 Kallikrein-1 Human 5850 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359681&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393197 386399135 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709642 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCCC4CO)c3)ccc12 InChI=1S/C27H28N6O2/c28-26-24-5-3-19(11-21(24)7-8-30-26)15-32-27(35)22-12-20(13-29-16-22)10-18-4-6-25(31-14-18)33-9-1-2-23(33)17-34/h3-8,11-14,16,23,34H,1-2,9-10,15,17H2,(H2,28,30)(H,32,35) CDKBTMZPQXYCQA-UHFFFAOYSA-N 359682 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[2-(hydroxymethyl)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 67::US11242333, Example 67 Kallikrein-1 Human 5150 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359682&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393174 386399136 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709643 CN(C)C1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C28H31N7O/c1-34(2)24-8-10-35(18-24)26-6-4-19(15-32-26)11-21-13-23(17-30-14-21)28(36)33-16-20-3-5-25-22(12-20)7-9-31-27(25)29/h3-7,9,12-15,17,24H,8,10-11,16,18H2,1-2H3,(H2,29,31)(H,33,36) SPGWHUUKFWWSEI-UHFFFAOYSA-N 359683 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 68::US10221161, Example 69 Kallikrein-1 Human 3510 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359683&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393169 386399137 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709644 CN(C)C1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C28H31N7O/c1-34(2)24-8-10-35(18-24)26-6-4-19(15-32-26)11-21-13-23(17-30-14-21)28(36)33-16-20-3-5-25-22(12-20)7-9-31-27(25)29/h3-7,9,12-15,17,24H,8,10-11,16,18H2,1-2H3,(H2,29,31)(H,33,36) SPGWHUUKFWWSEI-UHFFFAOYSA-N 359683 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 68::US10221161, Example 69 Kallikrein-1 Human 2430 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359683&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393169 386399137 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709645 CC(C)Oc1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C25H25N5O2/c1-16(2)32-23-6-4-17(13-29-23)9-19-11-21(15-27-12-19)25(31)30-14-18-3-5-22-20(10-18)7-8-28-24(22)26/h3-8,10-13,15-16H,9,14H2,1-2H3,(H2,26,28)(H,30,31) YKHQYVOPIDSSDX-UHFFFAOYSA-N 359686 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-[(6-isopropoxypyridin-3-yl)methyl]pyridine-3-carboxamide::US10221161, Example 70::US11242333, Example 70 Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359686&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393155 386399139 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709646 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(CO)C4)c3)ccc12 InChI=1S/C27H28N6O2/c28-26-24-3-1-19(10-22(24)5-7-30-26)14-32-27(35)23-11-21(12-29-15-23)9-18-2-4-25(31-13-18)33-8-6-20(16-33)17-34/h1-5,7,10-13,15,20,34H,6,8-9,14,16-17H2,(H2,28,30)(H,32,35) YHDQKRLULDVQCF-UHFFFAOYSA-N 359687 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 71::US11242333, Example 71 Kallikrein-1 Human 3950 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359687&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393164 386399140 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709647 CCOC(=O)C1CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C29H30N6O3/c1-2-38-29(37)23-8-10-35(18-23)26-6-4-19(15-33-26)11-21-13-24(17-31-14-21)28(36)34-16-20-3-5-25-22(12-20)7-9-32-27(25)30/h3-7,9,12-15,17,23H,2,8,10-11,16,18H2,1H3,(H2,30,32)(H,34,36) JLRATSDYYSCALN-UHFFFAOYSA-N 359688 Ethyl 1-{5-[(5-{[(1-aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-yl)methyl]pyridin-2-yl}pyrrolidine-3-carboxylate::US10221161, Example 72 Kallikrein-1 Human 3620 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359688&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393190 386399141 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709648 CC(C)N(C)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C26H28N6O/c1-17(2)32(3)24-7-5-18(14-30-24)10-20-12-22(16-28-13-20)26(33)31-15-19-4-6-23-21(11-19)8-9-29-25(23)27/h4-9,11-14,16-17H,10,15H2,1-3H3,(H2,27,29)(H,31,33) QHAUWEJXKZUUPP-UHFFFAOYSA-N 359689 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({6-[isopropyl(methyl)amino]pyridin-3-yl}methyl)pyridine-3-carboxamide::US10221161, Example 73::US11242333, Example 73 Kallikrein-1 Human 6690 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359689&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393184 386399142 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709649 CC1(C)CCN(C1)c1ccc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)cn1 InChI=1S/C28H30N6O/c1-28(2)8-10-34(18-28)25-6-4-19(15-32-25)11-21-13-23(17-30-14-21)27(35)33-16-20-3-5-24-22(12-20)7-9-31-26(24)29/h3-7,9,12-15,17H,8,10-11,16,18H2,1-2H3,(H2,29,31)(H,33,35) ZLDDWJIJDXHGIU-UHFFFAOYSA-N 359692 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[6-(3,3-dimethylpyrrolidin-1-yl)pyridin-3-yl]methyl}pyridine-3-carboxamide::US10221161, Example 74::US11242333, Example 74 Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359692&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393206 386399145 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709650 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccc(nc4)N4CCC(C4)C(O)=O)c3)ccc12 InChI=1S/C27H26N6O3/c28-25-23-3-1-18(10-20(23)5-7-30-25)14-32-26(34)22-11-19(12-29-15-22)9-17-2-4-24(31-13-17)33-8-6-21(16-33)27(35)36/h1-5,7,10-13,15,21H,6,8-9,14,16H2,(H2,28,30)(H,32,34)(H,35,36) SAVRWXYQJVOYRM-UHFFFAOYSA-N 359693 1-{5-[(5-{[(1-Aminoisoquinolin-6-yl)methyl]carbamoyl}pyridin-3-yl)methyl]pyridin-2-yl}pyrrolidine-3-carboxylic acid::US10221161, Example 75::US11242333, Example 75 Kallikrein-1 Human 10000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359693&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393191 386399146 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709651 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4=O)c3)ccc12 InChI=1S/C26H24N6O2/c27-25-22-4-3-18(11-20(22)6-8-30-25)15-31-26(34)21-12-19(14-28-16-21)10-17-5-7-29-23(13-17)32-9-1-2-24(32)33/h3-8,11-14,16H,1-2,9-10,15H2,(H2,27,30)(H,31,34) DWTKEQLXPBZTEF-UHFFFAOYSA-N 359694 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2-oxopyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 76::US11242333, Example 76 Kallikrein-1 Human 3750 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359694&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393217 386399147 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709652 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4)c3)ccc12 InChI=1S/C26H26N6O/c27-25-23-4-3-19(12-21(23)6-8-30-25)16-31-26(33)22-13-20(15-28-17-22)11-18-5-7-29-24(14-18)32-9-1-2-10-32/h3-8,12-15,17H,1-2,9-11,16H2,(H2,27,30)(H,31,33) OKYNKPFZSOLVQE-UHFFFAOYSA-N 359695 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(pyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 77::US11242333, Example 77 Kallikrein-1 Human 4800 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359695&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117890050 386399148 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709653 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCCC4)c3)ccc12 InChI=1S/C27H28N6O/c28-26-24-5-4-20(13-22(24)7-9-31-26)17-32-27(34)23-14-21(16-29-18-23)12-19-6-8-30-25(15-19)33-10-2-1-3-11-33/h4-9,13-16,18H,1-3,10-12,17H2,(H2,28,31)(H,32,34) RJFGZABUVYSVKX-UHFFFAOYSA-N 359696 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(piperidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 78::US11242333, Example 78 Kallikrein-1 Human 6930 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359696&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393189 386399149 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709654 CC1CCCN1c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C27H28N6O/c1-18-3-2-10-33(18)25-14-19(6-8-30-25)11-21-13-23(17-29-15-21)27(34)32-16-20-4-5-24-22(12-20)7-9-31-26(24)28/h4-9,12-15,17-18H,2-3,10-11,16H2,1H3,(H2,28,31)(H,32,34) QJOGYBUMALCINT-UHFFFAOYSA-N 359697 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2-methylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 79::US11242333, Example 79 Kallikrein-1 Human 7140 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359697&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393170 386399150 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709655 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(F)(F)C4)c3)ccc12 InChI=1S/C26H24F2N6O/c27-26(28)5-8-34(16-26)23-12-17(3-6-31-23)9-19-11-21(15-30-13-19)25(35)33-14-18-1-2-22-20(10-18)4-7-32-24(22)29/h1-4,6-7,10-13,15H,5,8-9,14,16H2,(H2,29,32)(H,33,35) OTPILUCJJKOWPU-UHFFFAOYSA-N 359698 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3,3-difluoropyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 80::US11242333, Example 80 Kallikrein-1 Human 7550 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359698&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393213 386399151 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709656 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(O)C4)c3)ccc12 InChI=1S/C26H26N6O2/c27-25-23-2-1-18(10-20(23)4-7-30-25)14-31-26(34)21-11-19(13-28-15-21)9-17-3-6-29-24(12-17)32-8-5-22(33)16-32/h1-4,6-7,10-13,15,22,33H,5,8-9,14,16H2,(H2,27,30)(H,31,34) PSHMRDARMQOLRC-UHFFFAOYSA-N 359699 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-hydroxypyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 81::US11242333, Example 81 Kallikrein-1 Human 9570 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359699&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393153 386399152 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709657 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(F)C4)c3)ccc12 InChI=1S/C26H25FN6O/c27-22-5-8-33(16-22)24-12-17(3-6-30-24)9-19-11-21(15-29-13-19)26(34)32-14-18-1-2-23-20(10-18)4-7-31-25(23)28/h1-4,6-7,10-13,15,22H,5,8-9,14,16H2,(H2,28,31)(H,32,34) UOVPCOMKDUSQBG-UHFFFAOYSA-N 359700 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-fluoropyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 82::US11242333, Example 82 Kallikrein-1 Human 4000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359700&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393198 386399153 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709658 CC1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C27H28N6O/c1-18-6-9-33(17-18)25-13-19(4-7-30-25)10-21-12-23(16-29-14-21)27(34)32-15-20-2-3-24-22(11-20)5-8-31-26(24)28/h2-5,7-8,11-14,16,18H,6,9-10,15,17H2,1H3,(H2,28,31)(H,32,34) BDDHAZOVAFLCQY-UHFFFAOYSA-N 359701 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-methylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 83::US11242333, Example 83 Kallikrein-1 Human 2870 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359701&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393220 386399154 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709659 CC1(C)CCCN1c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C28H30N6O/c1-28(2)8-3-11-34(28)25-15-19(6-9-31-25)12-21-14-23(18-30-16-21)27(35)33-17-20-4-5-24-22(13-20)7-10-32-26(24)29/h4-7,9-10,13-16,18H,3,8,11-12,17H2,1-2H3,(H2,29,32)(H,33,35) UUAUDGVZIJLYSI-UHFFFAOYSA-N 359702 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(2,2-dimethylpyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 84::US11242333, Example 84 Kallikrein-1 Human 10700 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359702&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393211 386399155 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709660 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCOCC4)c3)ccc12 InChI=1S/C26H26N6O2/c27-25-23-2-1-19(12-21(23)4-6-30-25)16-31-26(33)22-13-20(15-28-17-22)11-18-3-5-29-24(14-18)32-7-9-34-10-8-32/h1-6,12-15,17H,7-11,16H2,(H2,27,30)(H,31,33) WDTKDHOKUXYDRS-UHFFFAOYSA-N 359703 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(morpholin-4-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 85::US11242333, Example 85 Kallikrein-1 Human 8540 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359703&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393148 386399156 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709661 CN1CCN(CC1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C27H29N7O/c1-33-8-10-34(11-9-33)25-15-19(4-6-30-25)12-21-14-23(18-29-16-21)27(35)32-17-20-2-3-24-22(13-20)5-7-31-26(24)28/h2-7,13-16,18H,8-12,17H2,1H3,(H2,28,31)(H,32,35) CCWAWYXGGKGFJT-UHFFFAOYSA-N 359704 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(4-methylpiperazin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 86::US11242333, Example 86 Kallikrein-1 Human 4460 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359704&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393188 386399157 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709662 CCN(CC)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C26H28N6O/c1-3-32(4-2)24-14-18(7-9-29-24)11-20-13-22(17-28-15-20)26(33)31-16-19-5-6-23-21(12-19)8-10-30-25(23)27/h5-10,12-15,17H,3-4,11,16H2,1-2H3,(H2,27,30)(H,31,33) BSYLXGAPHBOLPP-UHFFFAOYSA-N 359705 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(diethylamino)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 87::US11242333, Example 87 Kallikrein-1 Human 4980 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359705&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393200 386399158 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709663 COC1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C27H28N6O2/c1-35-23-6-9-33(17-23)25-13-18(4-7-30-25)10-20-12-22(16-29-14-20)27(34)32-15-19-2-3-24-21(11-19)5-8-31-26(24)28/h2-5,7-8,11-14,16,23H,6,9-10,15,17H2,1H3,(H2,28,31)(H,32,34) AGESLAHMMMUCOA-UHFFFAOYSA-N 359706 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-{[2-(3-methoxypyrrolidin-1-yl)pyridin-4-yl]methyl}pyridine-3-carboxamide::US10221161, Example 88::US11242333, Example 92 Kallikrein-1 Human 9850 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359706&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393167 386399159 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709664 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCCC4CO)c3)ccc12 InChI=1S/C27H28N6O2/c28-26-24-4-3-19(11-21(24)6-8-31-26)15-32-27(35)22-12-20(14-29-16-22)10-18-5-7-30-25(13-18)33-9-1-2-23(33)17-34/h3-8,11-14,16,23,34H,1-2,9-10,15,17H2,(H2,28,31)(H,32,35) YEGMXIRGBOBRED-UHFFFAOYSA-N 359707 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[2-(hydroxymethyl)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 89::US11242333, Example 89 Kallikrein-1 Human 4840 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359707&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117889851 386399160 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709665 CN(C)C1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C28H31N7O/c1-34(2)24-7-10-35(18-24)26-14-19(5-8-31-26)11-21-13-23(17-30-15-21)28(36)33-16-20-3-4-25-22(12-20)6-9-32-27(25)29/h3-6,8-9,12-15,17,24H,7,10-11,16,18H2,1-2H3,(H2,29,32)(H,33,36) QLBNBADVDGUZLM-UHFFFAOYSA-N 359708 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 90::US10221161, Example 91 Kallikrein-1 Human 3880 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359708&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393168 386399161 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709666 CN(C)C1CCN(C1)c1cc(Cc2cncc(c2)C(=O)NCc2ccc3c(N)nccc3c2)ccn1 InChI=1S/C28H31N7O/c1-34(2)24-7-10-35(18-24)26-14-19(5-8-31-26)11-21-13-23(17-30-15-21)28(36)33-16-20-3-4-25-22(12-20)6-9-32-27(25)29/h3-6,8-9,12-15,17,24H,7,10-11,16,18H2,1-2H3,(H2,29,32)(H,33,36) QLBNBADVDGUZLM-UHFFFAOYSA-N 359708 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(dimethylamino)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 90::US10221161, Example 91 Kallikrein-1 Human 2110 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359708&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393168 386399161 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709667 Nc1nccc2cc(CNC(=O)c3cncc(Cc4ccnc(c4)N4CCC(CO)C4)c3)ccc12 InChI=1S/C27H28N6O2/c28-26-24-2-1-19(10-22(24)4-7-31-26)14-32-27(35)23-11-21(13-29-15-23)9-18-3-6-30-25(12-18)33-8-5-20(16-33)17-34/h1-4,6-7,10-13,15,20,34H,5,8-9,14,16-17H2,(H2,28,31)(H,32,35) KXOHCDTXIZSUSX-UHFFFAOYSA-N 359710 N-[(1-Aminoisoquinolin-6-yl)methyl]-5-({2-[3-(hydroxymethyl)pyrrolidin-1-yl]pyridin-4-yl}methyl)pyridine-3-carboxamide::US10221161, Example 92 Kallikrein-1 Human 7510 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359710&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393201 386399162 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709668 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3ccc(CN)cc3C)cc2)c1 InChI=1S/C27H29N5O/c1-19-13-31-32(17-19)18-22-5-3-21(4-6-22)10-24-11-26(15-29-14-24)27(33)30-16-25-8-7-23(12-28)9-20(25)2/h3-9,11,13-15,17H,10,12,16,18,28H2,1-2H3,(H,30,33) JKTKKPCPPHYQER-UHFFFAOYSA-N 359711 N-{[4-(Aminomethyl)-2-methylphenyl]methyl}-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 93 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359711&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117889648 386399163 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709669 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1 InChI=1S/C28H31N5O/c1-19-13-32-33(17-19)18-23-6-4-22(5-7-23)10-25-11-26(15-30-14-25)28(34)31-16-27-20(2)8-24(12-29)9-21(27)3/h4-9,11,13-15,17H,10,12,16,18,29H2,1-3H3,(H,31,34) QWAPEEDIDSKKLU-UHFFFAOYSA-N 359712 N-{[4-(Aminomethyl)-2,6-dimethylphenyl]methyl}-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 94 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359712&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117889922 386399164 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709670 Cc1cnn(Cc2ccc(Cc3cncc(n3)C(=O)NCc3c(C)cc(CN)cc3C)cc2)c1 InChI=1S/C27H30N6O/c1-18-12-31-33(16-18)17-22-6-4-21(5-7-22)10-24-13-29-15-26(32-24)27(34)30-14-25-19(2)8-23(11-28)9-20(25)3/h4-9,12-13,15-16H,10-11,14,17,28H2,1-3H3,(H,30,34) QDRGMOCPSUXWFS-UHFFFAOYSA-N 359713 N-{[4-(Aminomethyl)-2,6-dimethylphenyl]methyl}-6-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyrazine-2-carboxamide::US10221161, Example 95::US11242333, Example 95 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359713&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 117889949 386399165 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1 709671 Cc1cnn(Cc2ccc(Cc3cncc(c3)C(=O)NCc3ccc(CN)c(F)c3)cc2)c1 InChI=1S/C26H26FN5O/c1-18-12-31-32(16-18)17-20-4-2-19(3-5-20)8-22-9-24(15-29-13-22)26(33)30-14-21-6-7-23(11-28)25(27)10-21/h2-7,9-10,12-13,15-16H,8,11,14,17,28H2,1H3,(H,30,33) IZERGKYBLGUDKW-UHFFFAOYSA-N 359714 N-{[4-(Aminomethyl)-3-fluorophenyl]methyl}-5-({4-[(4-methylpyrazol-1-yl)methyl]phenyl}methyl)pyridine-3-carboxamide::US10221161, Example 96 Kallikrein-1 Human 40000 US Patent 10.7270/Q23B62DG aid1797759 US10221161 Edwards, HJ; Evans, DM; Meghani, P; Novak, AR 3/5/2019 10/20/2019 Kalvista Pharmaceuticals Limited http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=359714 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8441&target=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=359714&enzyme=Kallikrein-1&column=ki&startPg=0&Increment=50&submit=Search 121393212 386399166 1 MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS 1SPJ Kallikrein-1 KLK1_HUMAN P06870 Q66US9 Q86U61 Q8TCV8 Q9BS53 Q9NQU4 Q9UD19 Q9UMJ1